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In 1990 the Wellcome Trust created a History of Twentieth Century Medicine 
Group, associated with the Academic Unit of the Wellcome Institute for the 
History of Medicine, to bring together clinicians, scientists, historians and others 
interested in contemporary medical history. Among a number of other initiatives 
the format of Witness Seminars, used by the Institute of Contemporary British 
History to address issues of recent political history, was adopted, to promote 
interaction between these different groups, to emphasize the potential benefits 
of working jointly, and to encourage the creation and deposit of archival sources 
for present and future use. In June 1999 the Governors of the Wellcome Trust 
decided that it would be appropriate for the Academic Unit to enjoy a more 
formal academic affiliation and turned the Unit into the Wellcome Trust Centre 
for the History of Medicine at UCL from 1 October 2000. The Wellcome 
Trust continues to fund the Witness Seminar programme via its support for 
the Centre.
The Witness Seminar is a particularly specialized form of oral history, where several 
people associated with a particular set of circumstances or events are invited to 
come together to discuss, debate, and agree or disagree about their memories. At 
the time of publication, the History of Twentieth Century Medicine Group has 
held more than 50 such meetings, most of which have been published, as listed on 
pages xiii–xvii. 
Subjects are usually proposed by, or through, members of the Programme 
Committee of the Group, which includes professional historians of medicine, 
practising scientists and clinicians, and once an appropriate topic has been 
agreed, suitable participants are identified and invited. This inevitably leads to 
further contacts, and more suggestions of people to invite. As the organization 
of the meeting progresses, a flexible outline plan for the meeting is devised, 
usually with assistance from the meeting’s chairman, and some participants are 
invited to ‘set the ball rolling’ on particular themes, by speaking for a short 
period to initiate and stimulate further discussion.
1 The following is the standard introductory text to the Wellcome Witnesses to Twentieth Century 
Medicine series.
xEach meeting is fully recorded, the tapes are transcribed and the unedited transcript 
is sent to every participant. Each is asked to check his or her own contributions and 
to provide brief biographical details. The editors turn the transcript into readable 
text, and participants’ minor corrections and comments are incorporated into that 
text, while biographical and bibliographical details are added as footnotes, as are 
more substantial comments and additional material provided by participants. The 
final scripts are then sent to every contributor, accompanied by forms assigning 
copyright to the Wellcome Trust. Copies of all additional correspondence received 
during the editorial process are deposited with the records of each meeting in 
archives and manuscripts, Wellcome Library, London. 
As with all our meetings, we hope that even if the precise details of some of the 
technical sections are not clear to the non-specialist, the sense and significance 
of the events will be understandable. Our aim is for the volumes that emerge 
from these meetings to inform those with a general interest in the history of 
modern medicine and medical science; to provide historians with new insights, 
fresh material for study, and further themes for research; and to emphasize to 
the participants that events of the recent past, of their own working lives, are of 
proper and necessary concern to historians.
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Professor tilli tansey – professor of the history of modern medical sciences, Wellcome 
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introDUCtion
It is always a pleasure to take part in a Wellcome Witness Seminar, and this one 
was extra special as the fiftieth such event. Those 50 meetings are a remarkable 
contribution to the history of recent British medicine, one for which Tilli Tansey 
and her team deserve great credit.
For some of these Seminars the ‘pioneers’ are present,2 but in this meeting the 
key figures of the late 1940s and mid-1950s were represented mainly by the 
recollections of their younger colleagues, now mostly in retirement. Between 
them, participants recreated the histories of the first dialysis machines in Britain 
and how they were used. It is far from a simple tale, but very instructive. The 
machine at the Hammersmith Hospital had been offered by its Dutch inventor, 
Willem (Pim) Kolff, in part because the Hammersmith was the British centre 
for treating ‘crush syndrome’, which had been described there during the Second 
World War (page 8). But the dialyzer proved less than successful: patients could 
not be maintained for long periods, and other methods were developed to deal 
with acute renal failure – methods based on diet or potassium absorption that 
were more in line with the postwar push towards clinical physiology as the 
vanguard of clinical research. In England, though not in the US, it was primarily 
urological surgeons who imported dialysis machines in the 1950s and used 
them mainly on cases of septic abortion or on patients recovering from surgical 
operations of such severity as would not have been attempted before the Second 
World War. The leading physicians who had begun to specialize in kidneys were 
not much interested, though some of their juniors were, especially in university 
departments of medicine. At Leeds, the professor of urological surgery, Leslie 
Pyrah, had a background in physiology; he persuaded the hospitals to buy a 
machine from endowment funds and he supported dialysis in part though his 
Medical Research Council (MRC) grant for metabolic studies, even though the 
MRC was deeply sceptical of medical machines (pages 12 and 36).
One of the points of contention in the seminar concerned the credit for the 
technical devices which from c. 1960 made chronic dialysis possible, the work 
of Nils Alwall, and of the Newcastle group seem to have been under-rated, 
but all would agree that the development of the shunt points up the huge 
importance of apparently simple devices and the crucial roles of new materials 
2  See, for example, the transcript of the Witness Seminar held on 24 September 1993, ‘Technology Transfer 
in Britain: The case of monoclonal antibodies’, which was attended by the late Nobel laureates Dr Georges 
Köhler and Dr Cesar Milstein (Tansey and Catterall (eds) (1997): 1–34).
xx
in surgical technologies (pages 14–16). So too, the need for accurate and rapid 
measurement of electrolytes, for good laboratories, and for improvising new 
kinds of technical support. When dialysis started to become routine in the 1960s, 
British manufacturers took an interest, including both a major engineering firm 
and a specialist company, Dylade, set up by the father of Dr Stanley Shaldon, 
pioneer of home dialysis in the UK (pages 38–40). But as is often the case, the 
dialyzer market came to be dominated by US companies – which still raises 
questions about the role of central purchasing in the NHS.
Such technical and professional issues are becoming familiar in studies of the 
recent history of medicine, where simple invention stories will no longer stand up. 
Innovations are often incremental, different fields of patients were involved over 
time, professional attitudes differed between specialisms and places, and commercial 
power was often crucial. But this seminar also took us into more obviously social 
questions around home dialysis and the roles of nurses and patients. Here too, we saw 
both tangles of contingencies and persistent attitudes towards patient selection. At 
the start of the 1960s there was pressure for more dialysis centres, once chronic cases 
could be managed. Twenty centres were recommended in 1962, but simultaneously 
several of the existing centres had catastrophic outbreaks of hepatitis, that were 
very hard to manage before the Australia antigen tests became available, which 
could detect carriers of the disease. The reaction against this awful consequence of 
new medical technology was to limit the further development of centres, but, partly 
for that reason, Britain built an outstanding programme of home haemodialysis 
(pages 47–52).
Some of the most revealing parts of the seminar dealt with the experiences of 
nurses and patients as they shared with doctors the mutual education and support 
necessary for the maintenance of complex procedures in patients’ homes. Here 
was an exciting and influential departure from the usual hierarchies of medicine. 
Telephones were crucial for providing instant advice; social workers helped 
to arrange for modifications of homes and assisted in complex negotiations 
with patients’ schools and employers. One parent described her experience 
as ‘total immersion’ in the provision of dialysis for a child (page 60). Later, 
these programmes were much reduced, not just because kidney transplantation 
became more available, but because it sometimes seemed easier to deal with 
patients in kidney centres than to train and support them to self-dialyze.
Although the main focus of the seminar was on the UK, we also gained insights 
from the US and continental experiences of doctors trained in the UK. Seattle, 
Washington became a major US focus under Belding Scribner (the inventor of 
xxi
the shunt dialysis) and Christopher Blagg who had worked under Frank Parsons 
at Leeds. We learned that their independent renal centre was set up to limit the 
financial liability of the state (pages 27–8). That centre was at the heart of US 
debates about explicit rationing of medical care, and provision of dialysis under 
Medicare – a move that led to the massive growth of a dialysis industry. In the 
UK, rationing of dialysis treatment was sometimes explicit, but the selection 
often took place below the level of hospital departments. Even now, the UK has 
lower rates of treatment than most advanced countries. Is that because we are 
collectively sensible about end of life medical expenditures, or because doctors 
are too ready to decide there is ‘no need’?
Throughout the seminar – from crucial technicalities to the widest issue of ethics 
 – dialysis served as a wonderful case study. It was a privilege to see the details 
teased out and the narratives created. Such witness seminars do not attempt to 
be definitive, but they are and will remain both a major historical resource and 
a source of insights into the construction of histories. For this one we are much 
indebted to Dr John Turney of Leeds, who originated and shaped the venture, 
as well as to Professor Tilli Tansey and her excellent editorial team.
John Pickstone 
Centre for the History of Science, Technology and Medicine,  
University of Manchester
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Dr tilli tansey:  Ladies and gentlemen, welcome to this Witness Seminar on 
dialysis. My name is Tilli Tansey and I am the convenor of the Wellcome Trust’s 
History of Twentieth Century Medicine Group. We were established in 1990 
by the Wellcome Trust to bring together historians, scientists, clinicians and 
others interested in the history of recent medicine. One of the mechanisms 
devised was that of a Witness Seminar, where we get together a group of people 
who have been involved in a particular debate or discovery to discuss among 
themselves transitions in a particular subject: what happened, why and, more 
importantly, how? What were the factors that made some things successful and 
others less so? 
These meetings are recorded and transcribed and will be deposited in the archives 
of the Wellcome Library.1 Aditionally, we aim to publish an edited transcript 
and any further contributions you wish to make can be added as appendices or 
footnotes to the transcript, and will only be published with your permission. In 
this way, we build up a very valuable resource, both published and unpublished, 
for future historians of medicine and others interested in the history of recent 
medicine. This is the fiftieth such Witness Seminar we have run, so it is quite 
an anniversary, and we are delighted to have had the suggestion of a meeting on 
dialysis. The subjects of all our meetings are chosen by a programme committee; 
we receive between 20 and 30 suggestions each year, from which we select three 
to four meetings to hold and dialysis was ‘top of the pops’ this year. We are very 
grateful to Dr John Turney who suggested the subject, and who is also going to 
chair this meeting. So, without further ado, I will hand over to John.
Dr John turney:  Thank you everybody for coming and for taking the trouble to 
travel some not inconsiderable distances. We are very grateful. When I started 
attending and later presenting papers at the Renal Association held at the UCL 
Institute of Child Health, the formidable front row contained several of the 
people here today.2 Daniel had it easy, he only had to face lions. Therefore, as a 
cadet member of today’s group, I feel I am here merely to oil the wheels of your 
discussion. We have a draft outline programme of which you all have a copy, but 
this is for guidance of direction, not restriction of scope. As Tilli has said, we are 
1  The transcript, along with the records of this meeting will be deposited in archives and manuscripts, 
Wellcome Library, London, at GC/253.
2  The Renal Association, the professional body for nephrologists and renal scientists in the UK, was 
founded in 1950 and is active in planning and developing renal services and nephrology, the promotion 
and dissemination of research and education relating to the specialty. See www.renal.org/pages (visited 
14 November 2008).
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today writing an oral history of British dialysis and nephrology, and everybody 
here can contribute to that discussion. It is with pleasure that we welcome some 
distinguished historians of medicine, who will lend a historical perspective to 
our reminiscences, and help to guide and focus our thoughts.3 
We are taking the period from the end of the Second World War to about 
1980, because the 1980s saw profound changes in dialysis, with the advent 
of continuous ambulatory peritoneal dialysis (CAPD), the decline of home 
dialysis, changing patient populations, changing patterns of acute renal failure 
and, indeed, changing politics. If we make a satisfactory start today, if we are 
on our best behaviour, our hosts may consider a follow-up seminar to bring us 
more up to date. If we start at the beginning, we must acknowledge the postwar 
activities at the Hammersmith Hospital, London. 
Unfortunately, some of the key participants cannot be with us today, but we 
have a written submission from Professor Kenneth (Ken) Lowe, with whom 
I have been in correspondence, and some people may be interested in his 
recollections of the 1940s and early 1950s at the Hammersmith.4 The early 
attempts at dialysis and the development of the conservative regimen established 
by Graham (later Sir Graham) Bull are the backdrop to the events of the mid-
to-late 1950s.5 Others will talk directly or indirectly about their experiences 
at Leeds, Newcastle and elsewhere, as a handful of dialysis centres opened up. 
There may perhaps be mention of the role of the RAF, but, again, the original 
participants can’t be with us today. 
Others may wish to talk about the difficulties in learning to cope with an 
uncongenial technology; the numbers and types of patients, where they came 
from and where they had been prior to the availability of dialysis. I think we 
should touch on the ethics and process of patient selection and treatment 
withdrawal. Perhaps we should also consider the transition to a new way of 
practising medicine, which, after all, is what renal medicine is about, with the 
transfer from individuals with a machine to what we would now recognize as 
renal units with a multidisciplinary team with their own theatre of activity. 
3  This personal, contemporary approach extends and complements recent scholarship such as Peitzman 
(2007).
4  See Appendix 1, pages 79–83.
5  Sir Graham Bull’s conservative regimen for treatment of temporary renal failure involved control of fluid 
intake and diet, providing calories for nutrition with minimal waste, and isolation of the patient to prevent 
infection. See Bull et al. (1949).
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What were the circumstances? Was there resistance or encouragement for this 
new medical technology with all that it implied? 
Continuing chronologically, we will then consider the events and sequences of 
the 1960s revolution, precipitated by the Scribner shunt; a new disease defined 
by its technology; a new way of working; new problems presented by the 
technology; and by the fact that patients were now living beyond the point at 
which, without intervention, they would have died. I am sure we will consider 
hepatitis, aluminium and cardiovascular disease, among other problems. 
There were also problems of identifying, enumerating and selecting patients, the 
demands they put upon resources, and how these demands were met. This was 
the dawn of the political era of nephrology. The end-stage renal failure services 
were to remain contentious, not only in terms of finance, and overt and covert 
rationing, but also in terms of the clinical and ethical problems of starting, 
maintaining and ending treatment. I see the 1970s as a period when the pattern of 
renal services had settled somewhat, but it was a period of pushing the boundaries 
of the treatment. Doubtless our reminiscences will continue to centre on politics 
and resources, medical and psychological complications, the role and influence of 
commerce, and perhaps, the disappearance of British industry, changing roles of the 
members of the renal team, the patient population and its gradual empowerment 
with the rise and subsequent fall of that very British phenomenon, home dialysis. 
Doubtless too our conversation will move backwards and forwards in time as we 
follow themes. I don’t think that we should be constrained by period, place or 
subject. So that’s a little bit of the setting for this afternoon and it’s a great pleasure 
to introduce John Pickstone, Wellcome professor of the history of medicine at 
Manchester, who will give a historian’s perspective to our discussion. 
Professor John Pickstone: It’s a great pleasure to be here, and thank you for 
the invitation. May I also congratulate Tilli on 50 Witness Seminars, no mean 
achievement. 
Most of what I know about dialysis is from working with John Turney, but 
I have researched other technologies and other aspects of the health service. 
John asked me if I would give a few introductory remarks, chiefly to point to 
the fact that this is not just a history for those who lived it. It’s a history that is 
important for lots of people who are concerned with the relationships between 
medicine and society and particularly how these developed in the postwar UK. 
So, five brief points: one, of course, is that we should try to see things in 
context as far as possible, without the aid of that wonderful instrument – the 
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retrospectoscope. The great art is to recall and recreate what the problem was 
then, how it looked then and not to use later wisdom. And then, of course, 
was the postwar UK, which, as John has noted, was economically constrained.6 
There wasn’t much spare money for new hospitals or new facilities. On the 
other hand, one had seen a step-change in the funding for medical research 
and for salaries for hospital consultants.7 Many of the things that the Medical 
Research Council (MRC) had wanted to do during the interwar period were 
becoming possible in the postwar world through salaried consultancies, more 
drugs and more academic units. That context was undoubtedly very creative, as 
one knows also from work on artificial hips, or on cataract operations.8 
My second point is to underline the importance of what one might call 
communities of practice and the different ways in which people approach 
things. Clearly, one of the strongest aspects of British clinical medicine after 
the Second World War was what might be called clinical physiology, at the 
Hammersmith Hospital, London, but also nephrology in Manchester, with a 
great concern for analysing conditions, often using techniques that had been 
developed in physiology labs.9 Another aspect was the concern with diets and 
other forms of regimen. When one is talking about the contrasts between diet 
and technology, it is again important to try to get that into context. It’s easy 
to see diet as something very old, and technology as something essentially 
modern, but many of these diets were worked out by clinical physiologists, who 
thought that they could deduce them from their physiological results.10 That 
was exciting, that was an application of science, even if it wasn’t made out of 
metal or plastic. 
I would also emphasize the contrast between that community of laboratory, 
analytical physicians and the surgeons, who were also benefiting from the 
increasing funding under the NHS, but had very different research traditions.11 
If you think of the industrial model of research-and-development, surgery is 
much more like development than research: it’s about trying things which 
6  Hennessy (1994).
7  Hardy and Tansey (2006): 406, 417–22. 
8  See, for example, the introduction by Francis Neary and John Pickstone to Reynolds and Tansey (eds) 
(2006): xxv–xxix; Anderson et al. (2007).
9   See Booth (1993).
10  See McCance and Widdowson (1939). 
11  See Booth (1993).
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are very difficult to predict in principle, and building on that experience in 
a step-by-step process. One of the key issues with dialysis is the division of 
labour between surgeons and physicians and, to some extent, the emergence 
of physicians followed on from techniques. In the US, what you might call 
operative physicians, or technical physicians, became largely separate from 
other kinds of nephrologists. One sees that same tension in cardiology, which 
is an obvious comparison for nephrology, where some cardiologists became 
particularly interested in pacemakers and catheters, and to some extent in some 
contexts, this became a kind of sub-specialism.12 
But that’s moving on a bit. If we switch back to discussing the beginnings of 
dialysis, my fourth point is that one must ask what the technology was for at 
the time. The technology one knows later for chronic conditions was initially 
practised on acute renal failure.13 What was acute renal failure? It’s something said 
to have been discovered through trauma injuries in the Second World War, but 
once the war had ended there were far fewer of these trauma injuries. So, what 
then was the population with acute renal failure? And who in a hospital would 
know enough about the relevant obstetric conditions (e.g. septic abortions) to 
be able to link them with trauma and other conditions?14 Clearly the definition 
of that target population is partly a question of who knows these various groups, 
and can bring them together. As John Turney said, it was also a consequence of 
other technical developments, because patients who would have died quickly 
a few years earlier were not dying so quickly. They could be said to have acute 
renal failure and some of them recovered anyway. How could you help them 
through that? And how could new types of patients, with surgical trauma or 
inappropriate blood transfusions, also be ‘framed’ together and treated for 
‘acute renal failure’?
The last point is about how we make comparisons, especially between countries. 
It’s too easy to compare the place where things take off, which is usually the 
US, with the UK, and then to start looking for systematic differences between 
countries, for example, in general attitudes with respect to techniques. That 
approach always needs interrogating. One needs to ask just how many innovative 
places there were in the US, and how many places were ‘conservative’. If you 
mapped it out, would the countries really look so very different? Is this really 
12  See Bynum et al. (eds) (1985). 
13  See page 17. 
14  See, for example, Bull et al. (1955; 1956) and page 18.
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a question of national differences or is it something that should be explored 
through local differences and professional differences within countries, more 
than between them? 
Those are just five pointers to issues around this technology. I hope that that 
is helpful, but I am very much looking forward to learning the innards of the 
story from you. 
turney: We need to start at the beginning and we need a volunteer to start.
Professor sir Christopher Booth: Perhaps I could give my background. I went 
to the Hammersmith Hospital in 1952. I was Malcolm Milne’s registrar in renal 
disease at the Hammersmith between 1956 and 1957 and I knew Ken Lowe, 
because he went to Dundee just when I finished my time there in medical 
training at St Andrews. What happened at the Hammersmith, basically, was 
that it became the referral centre for acute renal failure, because of the crush 
syndrome work that Eric Bywaters had done in the early years of the war.15 
This was at a time when the crush injuries were sent to peripheral hospitals in 
London and not, obviously, to central ones, because they were late casualties. 
That work went well, and in 1945, as soon as the war was over, Bywaters legged 
it to the Netherlands and got an artificial kidney from Willem Johan (Pim) 
Kolff (Figure 1) and brought it back to the Hammersmith and Ken Lowe can 
remember using that kidney.16 He got very tired simply watching this rotating 
drum going round and round and round, and they didn’t have very good 
results. That resulted in Graham Bull, who was Bywaters’ successor as head of 
renal medicine at the Hammersmith, introducing his conservative regimen for 
the management of acute renal failure.17 That worked well; then he went off to 
Belfast and was succeeded in 1952 by Milne.18
Milne had no interest in dialysis whatever, he was a biochemist, but we still got 
cases with acute renal failure; they used to fly into the playing field next door to 
15  See, for example, Bywaters and Beall (1941); see also Bywaters (1990); Dixon (2003).
16  Professor Christopher Blagg wrote: ‘The artificial kidney used by Ken Lowe was one of four donated at 
the end of the war by Pim Kolff who had hidden them in 1944. They were sent to Bywaters and Joekes at 
the Hammersmith, Poland (this one ended up in Jagiello University in Cracow but apparently was never 
used), the Royal Victoria Hospital in Montreal, and Isidore Snapper at Mount Sinai Hospital in New York; 
see Broers (2007): 111–13.’ E-mail to Ms Stefania Crowther, 8 July 2009.
17  See Bull et al. (1953) and note 5.
18  See Peart (1995).
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the Hammersmith in air ambulances and we would be landed with somebody 
in acute renal failure. The major problem then was potassium – the patients 
died of hyperpotassaemia. So Milne’s first work at the Hammersmith was to 
work on the potassium-binding resins, which were just coming in at that time.19 
He did some very good work on that and we were able to save patients in acute 
renal failure by using those regimens. 
What happened next was that Belding Scribner (Figure 2) arrived at the 
Hammersmith.20 Scribner came as a research fellow with Milne, and my first 
experience of Scribner was seeing a great big round green glass bottle in a packing 
case in a hallway at the Hammersmith in the middle of 1956 with Scribner’s 
name on it. I had never heard of Scribner before. He came to dialyze via the 
stomach, gastrodialysis, with Milne. The reason he came to the Hammersmith 
was that it was a centre for referral for acute renal failure. It was he, I think, who 
basically pushed the idea that dialysis wasn’t a bad idea at all. 
19  See, for example, Black and Milne (1952). 
20  See Blagg (2006).
figure 1: Willem (Pim) Kolff (1911–2009).
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Then, in the spring of 1957, Milne and Professor Ralph Shackman, a urologist 
at the Hammersmith, brought back a rotating drum kidney from Paris.21 
I remember having to use that at the Hammersmith in the middle of 1957. 
We used to sit beside this great big beautiful stainless steel rotating drum and 
people would put their heads round the corner and say: ‘Frying tonight?’ But, I 
remember, it was something, of course, that was developed at the Hammersmith 
in surgery, not in medicine. The paper that Milne, Scribner and Crawford wrote 
while Scribner was there was published in the American Journal of Medicine in 
1958 and got a ‘citation classic’ in 1981.22 It was on non-ionic diffusion, which 
was Milne’s major interest in life and led on to his work on Hartnup disease and 
cystinuria.23 Milne stood aside completely, happy for his registrars to go along 
21  Professor Stewart Cameron wrote: ‘This was the French “Usifroid” modification of the Kolff–Brigham 
version of the rotating drum dialyzer.’ Note on draft transcript, 18 July 2008. Professor Christopher Blagg 
wrote: ‘The Usifroid Necker Hospital version of the Kolff–Brigham rotating drum artificial kidney was made 
by the Société Usifroid Paris about 1955 and was the one used by Ralph Shackman at the Hammersmith 
when he started the programme in late 1956.’ Note on draft transcript, 8 July 2009. See Appendix I, pages 
79–83.
22  Milne et al. (1958); Milne et al. (1981). 
23  See, for example, Milne (1969); Colliss et al. (1963); Milne (1967).
figure 2: Belding scribner (1921–2003).
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and help the surgeons. It was Shackman who developed dialysis, and that’s why 
it developed the way it did.24 
Professor Christopher Blagg: I’m originally from Leeds, now in Seattle. I first 
came back from the army in January 1958 to Leeds, where dialysis for acute 
renal failure had started in September 1956 with Frank Parsons (Figure 3) 
and Brian McCracken.25 If you read Stewart Cameron’s book you will know 
more about how this came about.26 Again, it was the surgeons. The professor 
of urologic surgery at Leeds, Leslie Pyrah, had invited Charles Huggins from 
Chicago to come and give a talk at the British Urological Association meeting, 
and as a ‘thank you’ for this, Huggins arranged for Frank to go to Chicago for 
a year, in 1953/4, to do cancer research.27 Frank took the last three months to 
go to Boston, to the Peter Bent Brigham Hospital, to John Merrill to see how 
24  Shackman and Milne (1957). 
25  Parsons and McCracken (1957; 1959), Hamilton (1984).
26  Cameron (2002): 124–5. 
27  For Frank Parsons’ account of these events and early dialysis at the University of Leeds, see Parsons 
(1989). 
figure 3: frank Parsons (1925–89). 
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acute renal failures were being treated.28 He came back to Leeds and, again, it 
was through the efforts of Mr Pyrah that they persuaded the Leeds General 
Infirmary to buy an artificial kidney, the Kolff–Brigham version of the rotating 
drum kidney (see an example of the type in Figure 4). 
On his return Frank had been appointed assistant director of the MRC unit for 
metabolic disturbances in surgery, Leeds General Infirmary, under Pyrah and, 
while the machine was in the mid-Atlantic, he was called down to the MRC for 
an urgent meeting, which lasted for about two hours, during the course of which 
he was told that there was no future for an artificial kidney in the UK, it was a 
mere gadget and that was the view of the MRC advisers. The parting words to 
Frank from Sir Harold Himsworth after the meeting were along the lines of: 
‘Parsons, try it, but remember the country is against you.’ But they couldn’t say, 
‘No’, because the infirmary had already bought the artificial kidney.29 
So, the programme started and it was a joint affair between the department 
of urologic surgery and the department of medicine, supported by Mr 
Pyrah and Professor Ronald (later Sir Ronald) Tunbridge and housed in the 
hospital’s new metabolic ward. As I think we will see later, in terms of what 
went on, it was just like the advent of chronic dialysis: the ‘establishment’ of 
renophiles in those days was totally against the idea and was unimpressed. 
So, for the first year or so, there were only the units at Leeds and at the 
Hammersmith Hospital and then, in 1957, Wing Commander Ralph (later 
Sir Ralph) Jackson started the unit at RAF Halton.30 Those are the beginnings 
of the process. 
Mr John Hopewell: Glasgow acquired a Kolff drum kidney in 1958. Did 
anything happen in Glasgow at that time?31 Sir Ralph Jackson gave many of us 
a lot of help in the early years. The late and revered Mary (Mollie) McGeown 
28  See, for example, Merrill (1952). 
29  Parsons (1989): 1559; see also Hamilton (1984): 92–3.
30  The RAF Hospital, Halton, was opened in 1927 and acquired a Kolff–Travenol type artificial kidney in 
late 1957. See Jackson (1958); Robson and Dudley (1958). See also www.raf.mod.uk/rafhalton/aboutus/
history.cfm (visited 14 October 2008). Early work on the theory of analysis from the Halton group can be 
found in Blackmore and Elder (1961). 
31  Professor Christopher Blagg wrote: ‘Arthur Kennedy, senior lecturer in medicine in the artificial kidney 
unit at Glasgow Royal Infirmary, came to Leeds in 1958 and we taught him about the use of the artificial 
kidney. They started up using an Usifroid rotating drum kidney, rather than a Kolff twin-coil kidney.’ Note 
on draft transcript, 8 July 2009. See Kennedy et al. (1961).
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came to London in 1958 and looked at the drum kidney at the Hammersmith 
and subsequently went to RAF Halton and chose to buy a twin-coil kidney, 
which Ralph Jackson was using at Halton.32 But I would like to hear what 
became of the RAF unit at Halton. You say it began in 1957. They were using 
that when I went to see Ralph in 1958. What became of it? I have applied to the 
RAF, but I can’t get anywhere, so far.
turney: Certainly Jackson and colleagues from the RAF did publish on what 
they called a mini-coil in the late 1950s.33 Perhaps Stewart can answer those 
questions?34
Professor stanley shaldon: Perhaps I could intervene before we move on. There 
are a few historical inaccuracies, which I personally would like to correct. I think 
32  Douglas (1998); Cameron (2000a).
33  Jackson (1958); Jackson et al. (1960). Professor Stewart Cameron wrote: ‘The “mini coil” was introduced by 
the Birmingham group in about 1963/4. See Cameron (2002): 160.’ Note on draft transcript, 18 July 2008. 
34  Professor Stewart Cameron wrote: ‘The Halton unit functioned until the late 1970s or the mid-1980s, I 
think.’ Note on draft transcript, 18 July 2008. 
figure 4: Kolff and Berk’s first artificial kidney with a drum of aluminium 
slats and a static open dialysate bath, 1942.
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the tribute for the arteriovenous shunt belongs to Professor Nils Alwall (Figure 
5).35 Scribner acknowledges this quite clearly in his first publication in 1960.36
turney: But it wasn’t a workable shunt.
shaldon: Excuse me, it worked very well. If you read his book he has 1500 cases 
treated with his shunt, and it was glass.37 What it didn’t do and neither did the 
original Scribner shunt – and this I can tell you from personal experience – was 
last. Scribner and Quinton’s had a rigid Teflon device which lasted approximately 
35  Professor Stanley Shaldon wrote: ‘In 1964, when the European Dialysis and Transplant Association was 
set up, I was a council member and Alwall was also on the council. During this time I became friendly 
with Alwall and he visited the National Kidney Centre in London in 1968/9 when I was working there, 
and gave me a personal copy of his book. Alwall was most interested in ultrafiltration. Indeed he named 
his artificial kidney the ultrafiltrator. He was responsible for treating many patients with congestive cardiac 
failure and ascites by ultrafiltration and indeed Kiil (who developed the first passive flow pumpless purpose 
designed artificial kidney in 1960, which became the routine dialyzer used by Scribner after he abandoned 
the Skeggs-Leonard kidney) quotes Alwall as his source of design to permit ultrafiltration.’ E-mail to Ms 
Stefania Crowther, 21 July 2009.
36  Quinton et al. (1960). 
37  Alwall (1963); see also Shaldon (2006). Alwall presented his findings in a paper entitled: ‘Fifteen hundred 
treatments with the artificial kidney (dialysis and ultrafiltration)’, at the First International Congress of 
Nephrology in September 1960. Professor Christopher Blagg wrote: ‘Alwall’s original experimental shunts in 
rabbits used glass cannulas that functioned for a week or so and he then used various modifications of these 
both in rabbits and in patients, but in his book he says he “abandoned the use of arteriovenous shunt or any 
other permanent cannulation, because of local infection and the difficulty of avoiding blood-clotting in a 
satisfactory way by heparinization” and does not say when he stopped using the shunt or how many patients 
he did not use the shunt in. (Alwall (1963)).’ Note on draft transcript, 14 July 2009. 
figure 5: left: Professor nils allwall. 
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six weeks, and if it hadn’t been for Wayne Quinton introducing a silicon rubber 
loop, there probably wouldn’t have been chronic dialysis successfully working 
anywhere in the world (Figure 6).38 So if we are going to recount history, let’s 
get it right. It was Alwall who invented the first shunt, a man not recognized 
outside of David Kerr’s unit in Newcastle, which had an Alwall artificial kidney. 
When I was Sheila Sherlock’s houseman in 1957, I first saw a patient die in the 
Hammersmith from cerebral oedema because the Kolff rotating drum had no 
means of ultrafiltrating. Indeed, before they could measure sodium correctly, 
which was mainly due to Merrill and the flame photometer, their kidney was 
thrown out of the Netherlands and Bull came in with the conservative regimen.39 
So, I think the perspective needs to be tightened a little on one’s recollections 
of this. Basically, Alwall is a neglected figure in the history of European dialysis, 
but he invented a shunt and he had patients living on chronic repetitive dialysis 
long before Scribner. Scribner acknowledged this.40
38  Scribner et al. (1960); Quinton et al. (1960). See also Clark and Parsons (1966). Hegstrom et al. (1961) 
concluded: ‘If cannulas are to last for long periods, care must be used during the cannulation procedure to 
make them mechanically perfect.’ Professor Christopher Blagg wrote: ‘Not everyone realized how true this 
was. In fact, the next article in the same journal described in great detail the problems with the Teflon shunt, 
some modifications to this and the first attempts to introduce silastic rubber tubing into the shunt to reduce its 
rigidity. (Nakamoto et al. (1961)) However, although silastic had been reported to retard clotting even better 
than Teflon, in the shunt it invariably clotted, see Quinton et al. (1961). Quinton went on to develop silastic 
tubing with an improved surface finish that did not cause clotting and improved cannula survival so that the 
silastic-Teflon arteriovenous cannula became the standard blood access device prior to the fistula. A paper 
from the Seattle Artificial Kidney Center in 1966 discusses cannula management in detail (Pendras and Smith 
(1966)).’ Note on draft transcript, 8 July 2009.
39  See note 5.
40  Professor Stewart Cameron wrote: ‘Clearly, in terms of public knowledge and acceptance, Scribner and Quinton 
made the breakthrough, with restoration of dying uraemics to relative health, even if Alwall first had the idea more 
than a decade previously. Scribner always denied he knew of Alwall’s work to begin with, saying to me (and to 
others) that if he had known of Alwall’s failure, he would probably not have tried the idea. Their first paper, 
however, quotes Alwall’s experiments (Scribner et al. (1960)). At the 1960 International Congress of Nephrology 
meeting in Evian, France, Alwall mentioned in discussion a patient who was oligo-anuric for seven months on 
dialysis and survived….Alwall virtually never comments on access, and in no patient’s death was inability to get 
access the reason – although poor blood flow is mentioned from time to time. This success may be because he 
used glass stoppers for his indwelling glass cannulas, which he left in place with heparinization. I – and I suspect 
many others – still used this simple technology (but without the glass stoppers) as late as 1962/3 for acute renal 
failure, even though the Teflon shunt had already been described and used and its application to acute as well 
as chronic renal failure suggested by Geoff Chisholm in Edinburgh in 1961 (Chisholm (1961)).’ Letter to Ms 
Stefania Crowther, 11 July 2009. Professor Stanley Shaldon wrote: ‘I wish to disagree with Professor Cameron, 
I remember very well that I heard Alwall describe the glass cannula shunt he had used to perform haemodialysis 
and indicated that he had reused these cannulas on several occasions by keeping the circulation running through 
the cannulas with a glass bridge to keep the access site open.’ E-mail to Ms Stefania Crowther, 21 July 2009.
History of Dialysis in the UK: c. 1950–1980
16
figure 6: top: Diagram of the technique of continuous haemodialysis.  
adapted from scribner et al. (1960). 
Bottom: arm plate and cannulas in place for long-term cannulation of arteries and veins.  
adapted from Quinton et al. (1960).
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turney: I take your point, Stanley. It is well made. We are thinking about 
dialysis in the UK primarily. The revolution that was precipitated by Scribner 
was his presentation at the annual meeting of the American Society for Artificial 
Internal Organs (ASAIO) in Chicago in 1960 and the shunt and building up 
the whole concept of the management of chronic renal failure.41 I merely used 
that as a pivotal date.
shaldon: I think that’s anecdotal. It’s just Anglo-Saxon arrogance, if you don’t 
mind the word. 
Professor stewart Cameron: I certainly would support Stanley in his eulogy 
of Nils Alwall, who was an extraordinary person, technologist, and clinical 
nephrologist, and who, in addition to the list of things Stanley mentioned, also 
introduced renal biopsy. This is often forgotten and only because he tried to 
biopsy somebody with a single kidney and lost that patient did he not publish 
his results in 1944, long before Iversen and Brun, and Muehrcke and Kark did 
ten years later.42 
Just a few points about the start of our retrospective history, because, 
unfortunately, we don’t have the individuals involved here to give us the 
primary evidence. Some of them are around, such as A M (Jo) Joekes.43 A point 
about the beginnings of dialysis: both Nils Alwall and Pim Kolff have always 
emphasized that they started off with the idea of treating chronic renal failure. 
At that time acute renal failure wasn’t much on the horizon; the term didn’t exist 
in the early 1940s. There were various people who had suffered various forms 
of acute renal failure, but the general concept of acute renal failure didn’t exist 
really until the later 1940s when it first started being used, around 1948/9.44 
Interestingly enough, one of the first people to use it in the sense that we do 
today was Homer Smith, a physiologist, not a clinician, in his book on the 
kidney, published in 1951 by Oxford University Press.45 And so, I think, the 
two medical pioneers in this area, Alwall and Kolff, started off with the idea of 
treating chronic renal failure.
41  Dr John Turney wrote: ‘ASAIO remained for years the main forum for dialysis in the US.’ Note on draft 
transcript, 10 July 2009.
42  Iversen and Brun (1951); Kark and Muehrcke (1954). 
43  Dr Joekes was unable to attend the Witness Seminar on 26 February 2008.
44  See Cameron (2002): 110–19.
45  Smith (1951).
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I would also like to second what was said about the heavy involvement of surgery 
and, of course, urology in particular, in the introduction of dialysis, not only 
internationally, but within the UK. If you tot up the dialysis units that began in 
the urological department or were heavily supported by a urological department, 
or primarily used by the urological department, you deal with almost all of the 
British units.46 The one exception to this trend was the US. The urologists in the 
US didn’t want to know. The few that did dialyze used peritoneal dialysis – it’s 
an interesting anomaly, perhaps not relevant to our discussion today.47 
It then came to be realized that long-term support of patients was not possible and 
acute renal failure, as it were, tiptoed sideways towards centre-stage in dialysis, 
but it was undoubtedly a secondary development. It’s interesting that there were 
a lot of acute renal failure patients around in the 1940s, mainly from mismatched 
transfusions because they were still sorting out blood groups,48 and from septic 
abortions.49 This latter group persisted longer in some of the countries where 
legislation or custom was perhaps less permissive, particularly in the Catholic 
countries, if one wants to be controversial. France, for example, continued to 
have patients with acute renal failure from septic abortions long after they had, 
perhaps not disappeared, but certainly become only a minor feature of the British 
landscape.50 So, if you like, the ‘easy-to-treat’ patients with acute renal failure did 
well on the conservative regimens of the late 1940s particularly pioneered at the 
Hammersmith, but elsewhere also, in the Netherlands, for example, as we have 
heard, by Gerd Borst.51 However, the surgeons were simultaneously beginning 
to ‘create’ more and more patients who needed acute dialysis because they had 
traumatic acute renal failure, not accidental trauma in fit young people, but 
much more deliberate trauma, often in rather ill people. The result was that 
these catabolic patients simply could not be managed conservatively and so 
one swung back to the idea that dialysis was a good idea, after it had been 
abandoned by almost everyone, even including people like Merrill. Just read 
what they were writing: Arthur Grollman, pioneer of peritoneal dialysis, what 
46  Cameron (2002): 124–5.
47  Cameron (2002): 134.
48  Cameron (2002): 111; Diamond (1980). 
49  See, for example, Bull et al. (1956). 
50  Richet (1999). 
51  Borst (1948). 
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was he saying in 1950?52 John Merrill, pioneer of haemodialysis, what was he 
saying in 1950?53 They said that dialysis is unnecessary and probably doesn’t 
work in the type of patient that they particularly saw at that time. I suspect 
that in the UK we had our own limb of that debate, which involved people like 
Eric Bywaters and Jo Joekes, who together did the first dialysis in the UK.54 It is 
worth remembering that they were actually only the third group in the world to 
do haemodialysis, after Alwall and Kolf. They were ahead of Murray in Canada 
by a few weeks, and ahead of everybody else.55 Also, I think I must put in a 
word for Michael Darmady, as I have written about him recently and I would 
refer you to the paper in Nephrology Dialysis Transplantation.56 Darmady did a 
huge amount, including building his own flame photometer in 1947 or 1948 
before any were available commercially. This group of people all did dialysis, but 
became disillusioned with it. When I interviewed Jo Joekes a few years ago for 
the International Society of Nephrology series of videotape recordings, I asked 
him what he actually felt himself at that time about conservative versus active 
treatment; he said that in 1950 he definitely supported the idea of conservative 
treatment and didn’t see a future for dialysis.57 But to answer one of the other 
questions, it was Joekes who later got on to Kolff, who, with Bruno Watschinger 
from Austria, then with Kolff in the US, had developed a disposable twin-coil 
kidney.58 It hadn’t even been published at that time, Jo told us in that interview 
(which by the way is available on the web). He decided to get one of the ‘earliest 
twin-coils’, and it was he who was responsible for advising the RAF to have a 
twin-coil kidney. 
Back to Guy’s Hospital, London: Alwall visited Guy’s in 1948 and dialyzed a 
patient with chronic renal failure with polycystic disease in the private wing 
with one of his own artificial kidneys.59 This dialysis had no impact on the 
52  See Muirhead et al. (1949); Grollman (1951); Grollman et al. (1951). See also Cameron (2002): 115.
53  Merrill et al. (1950). 
54  See Bywaters and Joekes (1948). 
55  See McKellar (1999; 2003).
56  Cameron (2007). 
57  A transcript of this interview is available online at http://cybernephrology.ualberta.ca/isn/vlp/Trans/
Joekes.htm (visited 18 March 2009).
58  Kolff and Watschinger (1956). 
59  Windschauer (1948). 
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desperate attempts of the nephrologist of the time, Arnold Osman, to start up 
a dialysis and renal unit at Guy’s, but Osman stayed down at Pembury Hospital 
in Kent.60 
Dr frank Marsh: I was a student at the London Hospital in the late 1950s 
and acute haemodialysis there started in 1958 or 1959 with the Kolff twin-coil 
kidney, run by a chap called Richard (Dickie) Balme, who is now forgotten 
in nephrological circles. He later became a gastroenterologist and later still a 
geriatrician. He was senior lecturer on the medical unit and ran the Kolff twin-
coil together with David Ritchie, senior lecturer on the surgical unit, who was 
appointed professor of surgery at the London Hospital Medical College in 1964. 
There appears to have been a bit of a battle royal between the surgeons and the 
physicians as to who should run it after the 1950s, and the physicians won. I 
remember vividly sitting over the Kolff twin-coil, whose coil was liable to break 
at any moment and spew blood into the bath. There were virtually no monitors 
on it and I remember sitting rather sleepily looking after an acute dialysis patient, 
looking at a trickle of yellow material coming down a tube which went into the 
blood line and realizing to my horror that in fact it was oil from a manometer. 
Dickie Balme, incidentally, also introduced peritoneal dialysis in the late 1950s, 
which was from a great big glass bottle. The London Hospital continued to use the 
Kolff twin-coil for acute dialysis until it started chronic haemodialysis with the Kiil 
flat plate kidney in 1965 (Figure 7),61 and in 1968 opened the first haemodialysis 
unit financed by the then Ministry of Health,62 which is another story. 
turney: Professor Kerr, you built an Alwall kidney?
Professor David Kerr: The Alwall was used first in Newcastle by Professor George 
Smart, a marvellous chap and the person who actually made the north of England 
a good place to go to, and that is why I was there. He was a wonderful man and 
brought in people from all parts of Europe, as well as the UK and from many 
60  Staff from Guy’s Hospital were divided up and relocated to hospitals in Kent during the Second World 
War. Osman chose to remain at Pembury Hospital to establish a renal unit there in 1944. See Cameron 
(1997). 
61  The Kiil flat plate kidney was introduced in 1960 by the Norwegian surgeon, Dr Fredrick Kiil. See Kiil 
(1960). Professor Robin Eady wrote: ‘The Kiil dialyzers consisted of a stack of three heavy slabs, or boards, 
of polypropylene, enclosing two layers of cellophane sheets that acted as dialysis membranes. These sheets 
were soaked in a sterilizing solution and, while still wet, were applied in pairs to the grooved surfaces of 
the boards, a two-person task. The artificial kidney then was tested for leaks by pumping air between the 
membranes noting any drop in pressure.’ Eady (2001): 24.
62  See Dathan et al. (1970).
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figure 7: flat plate kidney using Kiil membranes, c. 1965.  
above: Diagram of a continuous dialyzer adapted from skeggs and leonards (1948):  
‘the top rubber pad has been bent back to show the relative position of the  
Cellophane (C) and the fine groves (f) in the bottom rubber pad (G). a, B, D, e are inlet and 
outlet tubes for blood and dialyzing solution.’ 
Below left: soaking membranes. Below right: stretching membranes. 
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parts of the world. When I came to join him I spent a lot of time going round 
the world being looked after by friends of his. When I first came to see him, 
in 1959, he was using the Alwall kidney because among his friends he had the 
people across the North Sea in Sweden. So when he spoke to his friend Professor 
Alwall he got an Alwall kidney. When it was brought to Newcastle he had three 
people with him who helped him: Molly Hall, Walter Elliot and John Swinney, 
and three days later I was going to become the person to run the renal unit. They 
started with this and everything went wrong. The Alwall dialyzer consisted of two 
cylinders around which the blood was passed.63 Every time they did it, it started 
bleeding out. This went on for 36 hours with three people trying to do it and then 
finally the penny dropped: there must be some little bits on the side of it, which 
were breaking the cellophane. And so they called the dental chap, who came up 
and went over it, and found two little bits of stuff that was making holes. They 
were all standing on their feet but not using their minds. Anyway, they got it the 
thirty-first time, and it worked. I was on the way up to Newcastle that day; when 
I arrived Professor Smart had come to see what was going on and he pointed 
out that the blood wasn’t coming along. Of course, the people who hadn’t been 
to sleep for 36 hours had forgotten the heparin.64 Fortunately, the lady who was 
being treated was getting better and she started to pass urine normally. When I 
came to chat with her she said: ‘Oh, it’s wonderful that you have used this lovely 
machine and I got better.’ And I said: ‘Yes, yes, yes.’ This was in 1959; after that 
the artificial kidney worked perfectly well for the next year that we used it.65 
Dr rosemarie Baillod: I want to continue Frank Marsh’s observations on seeing 
dialysis as a student at the same time, in 1959. I remember going to see the 
Royal Free Hospital’s twin-coil kidney. I was not interested in the machine as 
my eye was taken by a lady who was weighing salts using laboratory scales. 
She was measuring the chemicals to make up the dialysate fluid. Nobody has 
mentioned that you could not do dialysis without a biochemist. I don’t know 
whether all departments had access to biochemistry at this time and whether 
this presented difficulties.
turney: I think that’s a very good point. The flame photometer has been 
mentioned and Kolff, of course, had access to a flame photometer. In Leeds, 
rapid, accurate biochemistry was key.
63  See Cameron (2002): 88–9; Maher (1989): 35. 
64  The anticoagulant heparin is still used in dialysis. See pages 44–5.
65  See Hall et al. (1961). 
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Blagg: We didn’t have a biochemistry department in Leeds. We had Frank Parsons, 
who had done this, I think, when he stayed in Boston, and I think he built his 
own flame photometer when he got back, but there was not a separate lab.
turney: I think he got an Eel prototype from Cambridge.
Professor sir netar Mallick: To reflect on the fact that there were nephrologists 
in the country at that time, as John Pickstone said, we had Sir Robert Platt 
(Baron Platt of Grindleford from 1967) in Manchester, who took distinctly no 
interest in the early history of these sorts of techniques as far as I could see. I 
was houseman on the urology unit in late 1960 to early 1961, when Platt was 
gifted a twin-coil kidney, which he promptly re-gifted to the urologists. As a 
houseman I was privileged to see this work and Platt, the very distinguished 
nephrologist, turned up about once a week to see what was going on. But it’s 
interesting to see how much the urologists really got it going here and how 
this highly intellectual group of physicians who were pushing renal medicine 
through the frontiers did not see dialysis as being at that level. 
Mr David Hamilton: I think we should get the flame photometer story clear, 
because it is a very crucial part of the history. Before that, could I urge the 
meeting to use a standard terminology about regime or regimen? Frank Parsons 
always insisted it was to be called regimen. Regime is: ‘we have seized the radio 
station and put a new government in.’ 
More seriously, Dr Kolff clearly acknowledged Mr Ruud Domingo, who lived 
across the road from him in Kampen, Netherlands. Domingo was charged with 
clearing or assisting the biochemical studies of reclaiming the Dutch polders 
after flooding and measuring the salt and chloride exit from the flooded polders. 
He had no uranyl acetate available, which was going off for cold war purposes. 
Mr Domingo is clearly acknowledged by Kolff and others, in the 1940s, for 
developing the flame photometer.66 Domingo came to Hammersmith and 
showed it to them. I am clear in my mind that Kolff had a flame photometer 
and Mr Domingo of Kampen was the innovator.67 
turney: When Frank Parsons retired I took over from him, but he never quite 
left the unit, and over interminable cups of coffee and his pipe, he told me 
that he thought the key to the Leeds team getting in early was their prototype 
66  Domingo and Klyne (1949); Drukker (1989).
67  See Appendix 2, pages 84–5. Professor Stewart Cameron wrote: ‘In fact, the principle of the flame 
photometer goes back to about 1928. The first practical flame photometers were developed independently 
around the mid-1940s by Domingo and by Phyllis Weald and John Peters at Yale.’ Note on draft transcript, 
18 July 2008. See Cameron (2002): 119, notes 21–2; Epstein (2001). 
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Eel photometer, because his previous work, of course, had been on colonic 
implantation of the ureters. So Frank actually came up through electrolyte 
physiological pathways, even though he had originally been destined to be a 
urological surgeon.
Dr John Goldsmith: Liverpool was one of the only places that had a district 
general hospital renal unit and it came about because a urologist called James 
Cosbie Ross was interested in renal tuberculosis and had come across a lot of 
such patients in uraemia.68 In 1956 he visited Frank Parsons in Leeds and took 
his ideas up enthusiastically, much against the prejudices of his various colleagues 
who thought that their own departments would be deprived of funds. He had a 
senior registrar, Eric Edwards, who was in the US at the Mayo Clinic at the time. 
Ross got him to bring back a Skeggs–Leonards kidney.69 In 1958, possibly 1959, 
but I think it was 1958, Professor Harold Sheehan, of the Sheehan’s syndrome, 
referred a patient to him with acute renal failure following a septic abortion and 
this was one of Ross’s first survivors.70 It might be of interest to people to know 
that Professor Sheehan used to obtain his post mortem material, namely the 
kidneys of women who had died of toxaemia, without opening the abdomen: 
he obtained his kidneys per vaginam without previously getting permission.
turney: That’s a hell of a colposcopy. The story that is coming out is of 
individuals, surgeons and others, interconnecting informally and formally, and 
doing things, which would, of course, be impossible nowadays. As Stewart 
Cameron has pointed out, dialysis could not be invented nowadays – or at least 
clinical dialysis could not be invented – because of the regulatory regimes now 
in place.
shaldon: For the accuracy of the flame photometer to be of any value in preventing 
dialysis disequilibrium, Merrill had to find a flame photometer that could easily 
be calibrated correctly. The inaccurate measurement of sodium through a flame 
was of no greater value than the chemical explanations of sodium. The only 
advantage of it was that it was quicker, but the standard error was something 
like ±5 per cent and the precision of the US version which could give you ±1 per 
cent enabled the dialysis sodium to be accurately balanced against the assumed 
or measured plasma/water sodium. 
68  See, for example, Ross (1953). 
69  Skeggs and Leonards (1948).
70  Sheehan and Davis (1958).
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Marsh: Not all biochemical measurements and dialysate prescriptions in the 
early days were quite as precise as we have heard. I vividly remember my first 
major contribution to nephrology was to find out from the technician for acute 
haemodialysis at the London Hospital what actually went into the bath of 
the Kolff twin-coil. It was, ‘a teaspoon full of this and a dessertspoon full of 
that’, and we finally came to the last thing and I said: ‘Well, what about that 
magnesium salt? We have got to make sure that all these things are packaged 
up and prepackaged so we know exactly what is going in. How much of that 
magnesium salt is there?’ The technician looked at me and said: ‘Oh, Dr Marsh, 
just a pinch.’ 
Dr Chisholm ogg: Following on from David Kerr: I worked for Jo Joekes from 
1964 when he was at the Institute of Urology, University of London, and it 
was my job to administer dialysis if anybody needed it. I spent a lot of time 
watching blood going round a twin-coil, but whenever I moaned about this, Jo 
would tell me that I didn’t know how lucky I was. He would recite innumerable 
stories about winding tubes of cellophane around drums, a process that seemed 
to take about 12 hours’ preparation before you got near the patient. He also 
made the point about leaks at the couplings at either end of the tubes, which he 
said were the bane of his life. The third point he made was that all the patients 
who were connected to this apparatus had major rigors, and that this was, again, 
something this modern, pre-packed, wonderful twin-coil kidney circumvented. 
I was actually jolly lucky to be allowed to sit there in peace and quiet.
turney: I think we have got to the early 1960s and maybe we can move into the 
era of dialysis for chronic renal railure.
Hopewell: Before we leave this period, I would like to suggest that dialysis 
had a role in the preparation of patients for transplantation. I know that those 
at St Mary’s Hospital, London, are generally regarded as being pioneers of 
transplantation in this country, which started in 1955 with Charles Rob and 
James (Jim) Dempster’s operation.71 Jim Dempster tells me that this was actually 
for acute renal failure and was a disaster. They relied on peritoneal dialysis in a 
proportion of their cases up until the mid-1960s. Whether a Witness Seminar 
on dialysis includes peritoneal dialysis, I don’t know, but I should very much 
like to ask the Leeds contingent – Dr Hoenich and others – whether Peter 
Raper’s historic transplant in 1959 had preparatory haemodialysis, or his other 
two in 1962 or 1963? Neil Turner has kindly told me that Michael Woodruff ’s 
71  Dempster (1953; 1956). 
History of Dialysis in the UK: c. 1950–1980
26
identical twin kidney transplant on the 31 October 1960 was dialyzed; but with 
what type of artificial kidney? He hasn’t told me yet.72 I wonder if anybody has 
any word about this early use of dialysis in that way.
turney: The first Leeds transplant, which was not a great success for various 
reasons, was performed on a lady with acute cortical necrosis following an 
antepartum haemorrhage that occurred on the seafront at Filey, which is not 
the centre of the medical universe. 
Shall we move on? We have had to guillotine this discussion, because peritoneal 
dialysis is a story in itself, it goes back and forwards, and then reappears and is 
reincarnated.73 We are really thinking haemodialysis up to about 1980 and how 
it all started in the UK. I know that is restrictive but otherwise, of course, this 
seminar could well finish in 2009. Shall we move on to talk about the transition 
into the chronic era, setting up chronic units and the transition from what was 
in many cases a surgically driven specialty as such, so that we can create a history 
of the specialty as well as a history of the treatment? We haven’t actually talked 
about where the nephrologists, as we call them now, were coming from. Was 
someone, somewhere, training nephrologists? Or were they people who came 
into it by accident, by inclination, by delegation? Would anybody like to set us 
rolling on this one?74
Blagg: To take up your question about where nephrologists came from: when 
Scribner was a research fellow at the Mayo Clinic, he heard John Merrill talk 
about the artificial kidney. Scribner had been interested in electrolytes since he 
was a medical student in San Francisco where one of his mentors was Thomas 
Addis and he thought that the artificial kidney could be a useful research tool. 
He had a serious congenital eye condition (he received one of the very early 
corneal transplants in the US) and so decided that he couldn’t go into private 
practice and would go into academic medicine. He happened to go to Seattle in 
the state of Washington on vacation with his family in 1951, before taking up a 
post in a New York hospital, and while there he looked up Bob Evans, who had 
72  See Woodruff et al. (1961). Professor Neil Turner wrote: ‘The patient is recorded as having a single dialysis 
treatment in Edinburgh on 8 October 1960, according to Dr Anne Lambie’s handwritten logbook.  That 
was three weeks before his transplant.’ E-mail to Ms Stefania Crowther, 1 July 2009. Professor Stewart 
Cameron wrote: ‘Edinburgh were then using a twin-coil kidney (since 1959).’ Note on draft transcript, 
18 July 2008.
73  For a history of peritoneal dialysis, see Cameron (2002).
74  See Appendix 1, page 79.
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been one of his teachers at Stanford Medical School. Bob was now physician-
in-chief at the Seattle Veterans’ Administration (VA) Hospital and he invited 
Scribner to come to the University of Washington Medical School. Robert 
Williams, the chief of medicine, made arrangements with the New York hospital 
and appointed Scribner an assistant in medicine at the Seattle VA Hospital, in 
1951, where he soon convinced the hospital to buy a Baxter–Travenol twin-coil 
kidney machine. He used to transport this in a truck to various Seattle hospitals 
to treat patients with acute renal failure.75 This continued until the point where 
we get to the start of chronic dialysis in March 1960. 
The situation then was the same as with the early days of dialysis for acute renal 
failure, in the sense that all of the early developments were done speedily, in a 
way that would not be possible today as there were no institutional reviews or 
ethics committees. The first patients had only a few weeks to live when they 
started on dialysis and they were treated without delay. New discoveries were 
made all the time and there was soon a small network of US dialysis physicians 
who were members of the ASAIO and they used to meet annually.76 In those 
days one would call friends to tell them what you had done today and tell them 
whether it worked or not to do it because this or that went wrong.77 
As with acute renal failure, the renal ‘establishment’, particularly renal 
physiologists, were very much against the idea of dialysis for chronic renal 
failure and said it would never work. After three of Scrib’s four patients had 
survived for some eight or nine months, he applied to the National Institutes 
of Health (NIH) for a grant to continue his work. The site committee visited 
Seattle in February 1961 and Scribner was told that they would not give him 
another grant to expand the programme because he wasn’t doing a controlled 
study. The antagonism to chronic dialysis continued for a number of years and, 
for example, when I chose to go to Seattle on an NIH research fellowship in 
1963, I was strongly advised by some not to do so. 
The turndown by the NIH was what led eventually to the establishment of 
the Seattle Artificial Kidney Center (SAKC) as the university hospital would 
75  Blagg (2006).
76  ASAIO first met in Atlantic City, New Jersey, in June 1955. It continues to hold an annual conference 
and publish a journal six times a year. See www.asaio.com (visited 25 March 2009). 
77  Professor Stewart Cameron wrote: ‘I founded and co-ordinated a very informal dialysis group in the UK 
during the 1960s – I think, 1965/6 – to broaden these conversations, tips, and to provide contacts and 
advice in those early days. See Cameron (2000a): 22.’ Note on draft transcript, 18 July 2008. 
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not allow any more patients to be treated because they were frightened that 
when the existing grant support ran out these expensive patients would become 
a charge to the state of Washington. So Scribner and James (Jim) Haviland 
established the SAKC as a separate, not-for-profit community-supported free-
standing dialysis unit that opened its doors on 1 January 1962 as the world’s 
first out-of-hospital dialysis unit.78 One thing they had found during the first 
year of chronic dialysis in the hospital was that there was no need for a doctor to 
be present all the time during dialysis as the technology was simpler than the old 
rotating drum and the patients were generally more stable than patients with 
acute renal failure. So dialysis became a nursing procedure, even though nurses 
were not allowed to start intravenous infusions in the state of Washington at 
that time.
Dr stanley rosen: You asked the question: ‘Where did the nephrologists come 
from?’ Originally I was interested in joining Sheila Sherlock as a liver registrar, 
but she said, ‘Stanley Shaldon is developing something, why don’t you work 
with him?’ So I went to the unit at the Royal Free Hospital where we did about 
six or seven years’ worth of work in about two years. It was a very exciting time, 
because Stanley was determined that we were going to develop a chronic dialysis 
system. Maybe I shouldn’t talk too much and let Stanley do it. After working 
78  The SAKC was renamed Northwest Kidney Centers (NKC) in 1970. For a history of the NKC, see 
www.nwkidney.org/nkc/aboutUs/ourHistory.html (visited 16 November 2008).
figure 8: Dr stanley shaldon at the royal free Hospital in 1966.
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with Stanley I went to join Merrill in Boston in 1964, and then came back to 
set up one of the first NHS-organized dialysis units in Leeds in 1966.79 I have 
a lot of stories to tell about all the various parts of my career, but I will defer to 
Stanley, except to say that the unit at the Royal Free, which he founded, was a 
hive of activity (Figure 8).80
shaldon: I think Jean Hamburger invented the term nephrology.81 There were 
people who were cardiologists with an interest in kidney disease, but there was 
no specialty in nephrology in my day, except at the Hammersmith Hospital, 
where I think it was called renal medicine; I don’t think it was exactly called 
nephrology. Hamburger and Gabriel Richet would insist that they introduced 
the term nephrology to the world,82 at the meeting they held in Evian, France 
– some of us were there – the first International Congress of Nephrology in 
September 1960.83 I was sent as a registrar who had left the eminence of the 
Royal Postgraduate Medical School to go with Sheila Sherlock, in November 
1959, to be supportive to her as the first full professor of medicine at the Royal 
Free Hospital, a female first. She was creating new posts and offered a lectureship 
79  Dr Stanley Rosen wrote: ‘Until 1966 dialysis for ESRD was provided by a few academic units to a 
negligible number of patients selected by happenstance. In 1966 prototype services were set up by a national 
governmental authority in an attempt to provide treatment for every patient that would benefit throughout 
the UK.’ E-mail to Mrs Lois Reynolds, 27 September 2009. 
80  Mr John Hopewell wrote: ‘This is a widely held belief, but is inaccurate. I, a urological surgeon, 
founded the renal unit at the Royal Free in 1957. In 1960 Stanley Shaldon joined the unit and developed 
maintenance dialysis from spring 1961, using twin Seldinger catheters in the femoral vein.’ Note on draft 
transcript, 18 July 2008. See Rae et al. (1963). Further comment by John Hopewell and the manuscript of 
his lecture, ‘Early history of the Royal Free Hospital renal unit’, delivered to the Old Student’s Association 
at the Royal Free Hospital in 2006, will be deposited, along with the records of this meeting, in archives and 
manuscripts, Wellcome Library, London, at GC/253.
81  Professor Stewart Cameron wrote: ‘There has been much argument and discussion over the origins of the 
terms “nephrology” and “nephrologist”. The earliest use – as opposed to a presence in a dictionary, which 
goes back to the mid-nineteenth century, both in France and the US – was by Arnold Osman of Guy’s and 
Pembury Hospitals in 1945.’ Note on draft transcript, 18 July 2008. See Cameron (1997): 1528.
82  Robinson and Richet wrote: ‘“Coinage” of the term “nephrologie” for use in the title of this first 
“International Congress of Nephrology” has been attributed to Hamburger…Whatever the truth, it is at 
least certain that Jean Hamburger identified and gave new life to an older word, one that now stands as the 
definitive descriptor of a new medical specialty.’ Robinson and Richet (2001): 6. 
83  The First International Congress of Nephrology, 1–3 September 1960, was organized by four national 
societies devoted to the study of the kidney: La Société de Nephrologie, the Scandinavian Society for Kidney 
Research, La Società Italiana di Nefrologia and the Renal Association of the UK, with the assistance of the 
American Society for Clinical Investigation and the Société des Eaux d’Evian. See Richet and Muller (2001).
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in nephrology to a young lady whom I knew at the Hammersmith and whom 
Chris Booth knew even better.84 I think it was one of the first appointments in 
the UK using the term nephrology and Sheila created this division, but the lady 
in question refused the post. So I was told: ‘You will become a nephrologist, you 
will go to Evian, and you will learn all about nephrology.’ There were 200 people 
there, mostly salt-and-water people who called themselves renal physiologists 
and Hamburger, who called himself a transplant nephrologist. 
Dr William Cattell: May I go back to your original question as to where the 
nephrologists, as we now call the doctors interested in dialysis, came from? My 
impression, and I am perfectly happy to be shot down, is that in the late 1950s 
to early 1960s nearly all the people were within professorial units or academic 
units. Here in London there were Stewart Cameron at Guy’s, Frank Marsh at the 
London, ourselves at Bart’s, Stanley Shaldon at the Royal Free and also David 
Kerr up in Newcastle. I make the point that in the early days of nephrology, it 
was heavily influenced, possibly for financial reasons, by academics. 
Goldsmith: I must have been the only non-academic nephrologist. Ever since 
my student days I have cut out articles from the BMJ and the Lancet, and put 
them in different files. I found out after a while that my renal file was twice 
as big as the others. Then, round about 1958, I helped to look after a familial 
outbreak of acute glomerulonephritis in four siblings, and I published this in 
the Lancet.85 Victor Pollak, who was working with Robert Kark at Presbyterian–
St Luke’s Hospital, Chicago, asked for a reprint. I thought, well, a BTA (Been 
to America) would be useful, so I wrote to him and asked if there was a job and 
there was! Six months before I was due to go there in 1959, I got a telegram 
asking whether I would be able to come three months early and work with 
Kolff, the inventor of an artificial kidney, at the Cleveland Clinic, Cincinatti, 
Ohio, and, of course, this was a wonderful opportunity. So I managed to work 
with Kolff and with Kark, and that’s how I became a nephrologist.
Marsh: At the London Hospital, nephrology was certainly driven through by 
the academics. It was largely driven by Clifford Wilson, who was appointed 
professor of medicine at the London Hospital Medical College in 1946. It 
was he who assured the governors of the London Hospital when they allowed 
treatment of the first few chronic patients in 1965 that it would only be for a 
very few patients, it would never take off, and it would cost virtually nothing at 
84  Dr Lavinia Loughridge FRCP was at that time married to Dr Christopher (later Sir Christopher) Booth.
85  Goldsmith et al. (1958).
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figure 9: Dialysis Patients of the royal free Hospital pictured in the Evening News, c. 1965.
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all. He knew exactly what he was doing. It was Clifford Wilson who drove it, 
and the people who ran chronic and, slightly earlier, acute haemodialysis at the 
London were all lecturers on the medical unit. They put in their own Scribner 
shunts. The first one I ever did was in about 1966. I had seen only one done, 
when a professor of, I think, mathematics at Queen Mary College came in with 
severe acute renal failure and Clifford told me that I was designated to put in the 
Scribner shunt. I said: ‘But Professor Wilson, I have only seen one done before’ 
and he said: ‘Marsh, I have the greatest confidence in you.’ 
turney: Did it work?
Marsh: Yes. Otherwise I wouldn’t be here.
turney: The other thing that was happening in the early 1960s – when dialysis 
medicine started to be practised in units that were actually separate from, 
although within, hospitals, and with their own staff – was the appearance of 
the specialist nurse. I wonder whether we can perhaps expand on that a little to 
bring in the other people?
Cattell: As people have said of their experiences, and I remember mine of the 
twin-coil vividly, there was usually a doctor present. The advent of chronic 
dialysis introduced the nurse specialist. I don’t believe we could have got off the 
ground with significant dialysis programmes without the help of the nurses. We 
have some of them here, who I am sure will contribute to this seminar.
Miss lesley Pavitt: I am slightly hesitant to start this because the lady who 
taught me everything I know, Mrs Ann Eady, is sitting in the front row. I 
was quite lucky to get to the Royal Free very early in 1967, at which stage 
dialysis was already a nurse-led programme, and I remember my very first 
day there, when the nurses had just made a decision not to tie the lines on to 
the Kiil any more. The consultant did a ward round and asked: ‘Why aren’t 
you tying them on? This is dangerous.’ The nurses said: ‘Well, they are fine 
if they don’t fall off ’, and then as he went out, they bleeped him when he got 
down the ward saying that the venous lines had all fallen off, and I thought: 
‘I have come to the maddest place on earth!’ It was very different, and coming 
from a traditional training hospital into that environment where previously 
everything you did was under the say so of the doctor, it initially seemed to 
me to be a very bizarre way of working. I think Bill Catell is right. I don’t 
think there were any other specialist nurses around in those days; we were 
probably some of the first.
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Mrs ann eady: I started in the renal unit at the Royal Free in about 1964. It was 
a slightly unconventional beginning, because I had had glandular fever so I had 
taken my state finals, but not my hospital exams, or vice versa. I was hanging 
around for three months and the matron asked me: ‘What would you like to do? 
We don’t know what to do with you.’ I said: ‘I would like to go and work with 
my colleague on the renal unit,’ so she said: ‘Hmm, yes’, and off I went. It was 
delightfully unconventional and suddenly we were not just nurses, we were also 
learning to be technicians. There were certainly no protocols, you were taught 
absolutely nothing in terms of ‘doing courses’. Health and Safety would have had 
a complete fit all round. It also taught me, I think, the resilience of humans. 
What I particularly enjoyed was teaching home dialysis to families, because this 
was the beginning of managing to put patients in their homes so that they could 
care for themselves. One other little thing about becoming a nurse specialist: 
when I worked at Guy’s Hospital with Stewart Cameron and Chisholm Ogg 
there were lines of patients waiting to have their needles inserted into their 
fistulas. Both Chisholm and Stewart were busy doing something or other and 
we nurses were standing around waiting. When finally they did appear they 
said: ‘This is ridiculous, would you like to learn how to do this?’ And we said: 
‘Yes, please!’ They said: ‘Right, OK, this is how you do it.’ And so we just learnt 
very, very quickly, and it was great. 
turney: And it was informal?
Mrs ann eady: Very. Very informal: ‘This is how you do it, OK.’
Baillod: We started a teaching programme in 1966 at the Royal Free. It was a 
formal programme, with lectures and a promotional booklet. We were able to 
get the matron’s support and permission to teach her nurses. At the time we 
were teaching patients and relatives to dialyze, so it was natural to include the 
nurses.86 There was a training programme then, but I don’t think they exist any 
more. It horrifies me, because we established training programmes in 1966 and 
kept them going because it was a way of recruiting staff for the department. 
Pavitt: Yes, I think they still do, but they are now run at universities and they are 
reasonably academic. Whether you would trust someone with that certificate to 
actually dialyze you is another matter.
turney: The other issue is that they recruit people as students who are already 
doing it. So I think the point about practical training has gone. And if you 
86  See Baillod et al. (1967).
History of Dialysis in the UK: c. 1950–1980
34
can say that doctors delegated to nurses, nurses now delegate to non-registered 
general nursing staff, so it really has moved away from the original pattern. And, 
of course, nowadays the machines look after themselves.
Dr roger Greenwood: I was a latecomer to all this, but I am interested to know 
when non-registered nurses first appeared in the specialty, because they have 
become a very significant part of the workforce now. I understand they were first 
introduced in Kent and Canterbury Hospital, but I may be completely wrong. 
I would be interested to know, also, if any other specialties had contemplated 
non-registered nurses being so involved in patient care, or was it first seen in 
renal units?
turney: I think this is a very important point, because in Leeds they called 
them technicians, but these were unqualified people by any medical standards, 
who were recruited from the general community, from shops and wherever, to 
provide the dialysis service. 
Baillod: I have been waiting for Stanley Shaldon to mention the Royal Free, 
but he hasn’t done so yet. The original machine was acquired and used by Mr 
Hopewell and then, as Stanley said, he was sent to the Hampstead branch of 
the Royal Free to develop and use it. At one point we managed to fall out with 
the matron and we did not have nurses, so we employed our own nurses as 
technicians. Stanley, you must remember this?
shaldon: I certainly did not accept a lectureship in nephrology to be a dialysis 
doctor. I don’t wish to disparage the profession, but I thought I was in academic 
medicine, and was more interested in measuring renal blood flow by using 
cardiac catheters than dialysing patients.87 John Hopewell had the artificial 
kidney and indeed he was gracious enough to allow us to start treating patients 
with acute renal failure in 1961. Interestingly, because of our cardiac catheter 
and organ blood flow techniques, we were very familiar with using the Seldinger 
technique,88 so we managed to make ourselves independent of the surgeons 
who were never around when we needed to dialyze, and we could insert 
catheters ourselves instead. This was not due to the surgeons’ unwillingness, 
but usually they were operating when we needed them to cut down and put  a 
piece of tubing into the artery and a piece of tubing into the vein, which was the 
standard approach to the emergency dialysis system in those days, not a Scribner 
87  See, for example, Shaldon et al. (1962).
88  See Seldinger (1953).
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shunt. So it was really by chance, if you will, that I got involved with dialysis. 
The way you end up in life is never the way you planned it. Certainly, as an 
academic lecturer in nephrology and going to the first International Congress of 
Nephrology, I didn’t see myself in those days as the person I seem to have ended 
up as, but I guess that’s life.
Blagg: Three quick points: I had no intention of being a dialysis doctor, but 
within days of my arriving back in Leeds in January 1958 as a research fellow 
interested in thyroid disease, Brian McCracken’s son was killed in an accident 
and Brian left to go back to the US, as his wife was American. I was bottom 
of the totem pole and was told: ‘The artificial kidney is yours.’ I was now the 
department of medicine’s representative and was told to go to work with Frank 
Parsons. In terms of technicians, as John mentioned, we didn’t have a technician 
at that time and for two years Frank and I did it all ourselves with some help 
from urology registrars, including sterilization and then winding the cellophane 
tubing on to the drum and all those sorts of things. The technician we eventually 
acquired was a hospital porter, Brian Auty, and he turned out to be superb and 
stayed with the unit until he retired. So you didn’t need to be very skilled in 
those days when we were all learning how to do dialysis. 
turney: Yes, I remember that technician. Frank Parsons bequeathed him to me. 
He looked after me very well.
Booth: May I ask two general questions? One relates really to academia, and 
the other to money. As far as academic medicine is concerned in London, one 
has to recall that until the end of the war there were only five professors of 
medicine in the 12 undergraduate schools in London. The Royal Free got its 
first professor in Sheila Sherlock (later Dame Sheila) in 1959, Westminster in 
1960 got Malcolm Milne, and the last undergraduate professor of medicine to 
be appointed in London didn’t get appointed until 1964, and that was John 
Anderson at King’s.89 So academic medicine as we now know it was very much 
a young and tender flower then. The other professors who had been there 
right up until, say, 1960 had a battle establishing themselves among the part-
time consultants who arrived in their Rolls Royces. As Francis Fraser always 
said when he was at Bart’s, it is very difficult to recruit people to academic 
medicine when they could see Lord Horder arriving in his Rolls Royce. There 
89  Dr Frank Marsh wrote: ‘The first professor of medicine at the London Hospital was Arthur Ellis, 
(previously Regius professor of medicine at the University of Oxford) when he was also consultant physician 
and director of the medical unit at the London Hospital.’ E-mail to Ms Stefania Crowther, 7 August 
2009.
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was a financial disincentive in academic medicine; you earned much less. You 
didn’t do private practice, not in those days, so you were poorer as far as your 
lifestyle was concerned. There were problems. That was the first problem in 
recruitment. 
The second problem was the MRC. I know about the unit in Leeds, but could 
somebody say whether the national body for medical research in this country 
became involved in dialysis at all, because their attitude to Denis Melrose 
when he was developing the pump for cardiac surgery was: ‘Oh no, that’s mere 
technology.’ I don’t know what the MRC did about dialysis. I do know what 
they did about Roger Williams trying to develop an artificial liver at King’s, 
which was unsuccessful.90 
turney: I think David Hamilton will support me from his researches: as far as 
I can make out, Leslie Pyrah slipped Frank Parsons and dialysis into this and 
the MRC never officially approved or disapproved. They just accepted it as a 
fait accompli and, provided that publications were coming through, they were 
willing to do so. I don’t think they thought that dialysis was anything more than 
a little experiment that wouldn’t last. And, because transiently Leeds and the 
Hammersmith looked after the whole of the UK, Leeds got patients coming 
from Glasgow, Belfast and all over and they were swamped. The MRC said: 
‘Well, that’s unfortunate, but your job is actually to be the assistant director of 
the unit.’ So that’s the only time they actually ever expressed an opinion; they 
mainly kept themselves aloof. I think that’s right, isn’t it?
Hamilton: Just to confirm that: I dredged my way through the MRC records 
in the National Archives, at Kew, for this very matter and it’s clear that Pyrah’s 
skill was spending MRC money for biochemistry on dialysis. Biochemistry was 
the MRC’s priority at that time; understanding the internal chemistry of the cell 
was going to produce the goods in the long term, and they were looking long 
term. So, to give them their due, that was their priority, and Pyrah’s skill was to 
use this big grant for a chemical unit and skilfully divert energies and resources 
into the kidney work, as it happened.91 
turney: One little thing on this particular point: we have to remember that 
Leeds General Infirmary was possibly the second richest hospital in the country 
90  See Melrose (1953); Williams (1978).
91  The MRC metabolic disturbances in surgery unit, Leeds General Infirmary, was established in 1956 
with Professor Leslie Pyrah as honorary director, until 1964, when Professor B E C Nordin was appointed 
director. See Hamilton (1984).
History of Dialysis in the UK: c. 1950–1980
37
and the special trustees or the board had about £1 million to dispose of as they 
wished, which in 1956 was a huge amount of money. So, buying this machine 
for c. £2500 was small change. The huge support came internally within the 
hospital, nursing staff, junior doctors being seconded by the professor of 
medicine and things like this, so I think that’s how it got going in Leeds.
Cattell: We are now on something we touched on earlier, which was the 
resistance of the medical establishment to the development of dialysis. My old 
boss Max Rosenheim, who had considerable influence with the MRC, was 
utterly opposed to dialysis.92 One of his successors, whom you all know, Oliver 
Wrong, once assured me that I had given up being a doctor and was now a 
plumber.
Professor robin eady: Perhaps my perspective is somewhat different because, 
as some of you know, I am a renal patient as well as a doctor (Figures 9 and 
10). I was a clinical student at Guy’s Hospital in 1962 when I became very ill 
with very high blood pressure and rapidly declining kidney function. Sadly, 
Stewart Cameron wasn’t around at Guy’s at the time and they didn’t feel that 
they could do much for me. I found myself in the Hammersmith and was 
under Ralph Shackman and Sir John McMichael, and in fact, that culture 
about dialysis that Bill Cattell has just mentioned was very prevalent. I had 
to be treated conservatively and there was some suspicion about dialysis and 
this rather strange chap Scribner, who had been a fellow at the Hammersmith 
Hospital earlier, as we have heard, and had fiddled around with electrolytes and 
developed this programme. I have to say that, apart from one person – in fact 
it was Colin Dollery – there was very little encouragement for me to go to start 
dialysis in the US, which I did as a patient of Scribner’s exactly 45 years ago.93 
If I could just say that I was also a very early renal technician and even in 
1963 we were still weighing up the chemicals in order to make the fluid and 
we didn’t have a flame photometer available. However, one of Scribner’s other 
inventions was a bedside kit that allowed one to get a rapid and, I think, 
reasonably accurate estimation of chloride, using a small resin column. We used 
92  Lord Rosenheim (Baron of Camden) chaired the Ministry of Health committee on intermittent dialysis, 
1964–66, which reported in favour of dialysis. Dr William Cattell wrote: ‘Lord Rosenheim was a very 
discreet operator and never published controversial material. My comment relates to a personal conversation 
with Lord Rosenheim when I came back from the US in 1964 and battles were going on between Stanley 
Shaldon (aided and abetted by Hugh de Wardener) and the department. I sought his advice about the future 
of renal medicine at Bart’s.’ Letter to Ms Stefania Crowther, 7 July 2009.
93  See Eady (2001, 2008).
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that fairly successfully.94 I don’t remember any tragedies as a result of bad fluid 
compositions, but it was a refrigerated system and perhaps we will come on 
to the development in the early 1960s later on. That was my recollection and 
you are absolutely right, there wasn’t great encouragement from many of the 
prominent academic physicians to enter a dialysis programme as a patient.
turney: I think that’s fascinating and we will be coming back to you later. We 
have mentioned the Kolff twin-coil that became Travenol. Can we start bringing 
in the role of industry and the technical developments? What happened to 
British industry? I remember when I started, Lucas and Cambridge machines 
were the only ones that seemed to have a government kite mark or whatever 
they had at that time.
Mr eric Collins: I seem to be the only ‘beastly commercial’ here. I think the 
fact that so many British medical companies have disappeared is a tragedy.95 
The reasons must be many and varied, but it must have something to do with 
the culture of the time. British companies appeared to be reluctant to engage 
outside the UK. The companies you mention, such as Lucas, Cambridge and 
many others, including Watson-Marlow, all had the ability to produce and 
94  See Scribner (1950).
95  See Tansey and Christie (eds) (2000): 27, 32, 34–6.
figure 10: robin eady receiving haemodialysis in the ‘side room’ of the  
royal free Hospital renal unit in 1966.
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develop dialysis equipment to the demands of the doctors and to the special 
requirements of Dr Shaldon and others who were sending patients home to 
treat themselves. In the late 1960s and early 1970s, dialysis equipment was 
purchased on central contract and delivered to hospitals as and when required.96 
The demand for machines in the UK was disproportionately high because of 
the demand for home treatment, even though the total dialysis population was 
much lower here than, say, Germany, France and Italy. The companies therefore 
did not have to work particularly hard to make a decent business. Perhaps they 
got fat and lazy. If that seems unfair, I would like to make the point that central 
purchasing did not, in the end, do British industry many favours.
shaldon: I would like to put an alternative view, as somebody who was involved. 
In fact, Dylade was the company, if you check the company’s register, which was 
founded by my father for me in 1965 and the idea was that it would provide 
dialysis for home dialysis patients. Indeed, it was bought by an American 
company called Milton Roy, which was the first to produce, with the help of the 
Scribner engineering team, a properly designed automated system for dialysis, 
which preceded the Lucas machine and others like it.97 It worked very well, but 
it was rather over-sophisticated in its rather poor soldering of the circuit boards 
that controlled the alarm systems and the logic. The first models were built, in 
fact, for Scribner in 1964 and they abandoned this machine, curiously enough, 
and went for a much simpler machine made by Drake Willock.98 We persevered 
with the Milton Roy machine, which then became the Dylade machine and 
which was supplying most of the European markets in competition with Drake 
Willock. So, there was a distinct element of British scientific engineering that 
went into producing a workable dialysis machine, which in fact went all round 
the world. We put machines, later on, as far afield as Colombo, Sri Lanka, so I 
don’t totally take Eric Collins’s view of this, because Gambro were a latecomer 
96  See McBride (1979). Mr Eric Collins wrote: ‘The contracts for dialysis machines emanated from the DHSS 
technical branch, Russell Square, London. Cambridge Instruments, Lucas Medical and Watson-Marlow 
eventually all disappeared from the market. These were all (as far as dialysis was concerned) only small divisions 
of much larger companies. Dylade were successful internationally and were only taken over by the German 
company Fresenius in 1985.’ Letter to Ms Stefania Crowther, 6 July 2009.
97  Professor Christopher Blagg wrote: ‘The Milton Roy dialysis machine was based on a machine developed 
by Les Babb, professor of nuclear engineering at the University of Washington for use by Seattle’s first home 
haemodialysis patient in 1964. (See Babb (1995))’. Note on draft transcript, 8 July 2009.
98  The Drake Willock machine was created by Richard Drake and Charles Willock in Portland, Oregon, 
in 1964. For an interview with Richard Drake see: www.voiceexpeditions.com/index.php?id=230 (visited 
1 April 2009). 
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to this field.99 Their machine was a sort of stainless steel monster from Lund, 
which nobody in their right mind would have used to start with, and it took 
them some time.100 Don’t you agree?
Baillod: It was huge, but then the next ones came along.
shaldon: Yes, the next one came along, because they took the Milton Roy 
pumping system from the US, which was the heart of the machine.
Collins: Yes, it was a monster, and in consequence of that, of course, it was never 
used in the UK; it was never presented to the UK, and we didn’t really start until 
the late 1970s.
Dr nicholas Hoenich: Perhaps I could just come back and say a little bit about 
what Eric Collins said before. I think one of the things that we do forget is that 
many of the items of equipment that we take for granted were all purchased 
under central contract after 1969, which was at that time handled by the 
Department of Health and Social Security (DHSS). I think Eric is right that 
there was reliance within companies on these DHSS contracts. I recall that one 
of the first tasks I was given when I went to Newcastle in 1968 was to evaluate 
the Heppell and the Watson-Marlow Kiil-type dialyzers with a view to deciding 
which one the DHSS was going to issue on central contract.101
99  Gambro began mass production of dialysis machines in Lund, Sweden, in 1967. See Gambro (2006). See 
also www.gambro.com/int/About-Gambro/The-Gambro-Story/ (visited 1 April 2009)
100  Gambro (2006): 16–17. 
101  Hoenich et al. (1970). Dr Nicholas Hoenich wrote: ‘A working party on intermittent dialysis for chronic 
renal failure was set up in 1965 under the chairmanship of Hugh de Wardener to advise the Minister of 
Health on clinical policy and on the development of equipment. Clinicians were dissatisfied with equipment 
that would not perform correctly and the working party requested that the Ministry of Health (MoH)
carry out independent trials of all equipment. The scientific and technical branch of the MoH’s supply 
division contracted the Atomic Weapons Research Establishment (AWRE) to undertake prototype or 
early production models of single patient haemodialysis machine evaluations at Aldermaston, Hampshire. 
The AWRE was selected because it had a team of government scientists with a working knowledge of the 
techniques and engineering methods in use in haemodialysis machines (see Robinson (1974)). This led 
to a similar contract programme being established at Newcastle upon Tyne for haemodialyzers. A more 
formal funding arrangement on a three-year rolling budget followed and the programme was integrated 
into the evaluation programme funded by the DHSS scientific and technical branch. This programme was 
subsequently embodied into the DHSS/NHS procurement directorate and ran until 1996. Data collected 
in the course of the programme was disseminated in the form of individual reports to each of the renal units 
in the UK and also formed the basis of a public domain review article in Artificial Organs (Woffindin and 
Hoenich (1995)).’ E-mail to Ms Stefania Crowther, 30 June 2009.
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turney: So, there was quite a lot of control at that point, into the 1970s.
Dr felix Konotey-ahulu: I am wondering whether I could underline three 
historical aspects, which I think are important. The first is the spirit of dedication 
in the renal units, the second is the accuracy of the laboratories and the third is 
clinical acumen. I got into dialysis as a result of ending up at the Hammersmith 
Hospital as a postgraduate student. After his lecture, Dr Gerry James came over 
to me and asked me what I was doing in England, and I said that, having trained 
at the Westminster Hospital, I had gone home to find that I saw more high blood 
pressure and kidney failure in Ghana in six months than I had seen in three years 
in Westminster. I had come to England to see if I could do work on kidneys. 
So he said: ‘Oh, I will introduce you to my wife; she is called Sheila Sherlock 
and she has a kidney unit.’ So, within a week I met with Dr Sherlock. She didn’t 
even interview me at all; she said: ‘I am going to assign you to a gentleman called 
Stanley Shaldon, who will look after you.’ So I met Stanley in the early 1960s. 
The first thing to mention about that unit at the Royal Free is the dedication: 
the dedication of the leadership in dialysis was extremely important in those 
early days. I would be in the dialysis room and Stanley Shaldon would turn up 
unexpectedly and look at the drip and if he found a bubble in the wrong place, 
he would say: ‘Come on, move, Felix, we are not in the jungle, come on, move, 
hurry up.’ With this kind of frank exhortation we all bucked up. I remember 
Robin Eady on dialysis in those days. At the end of the day Stanley Shaldon 
would come round and say: ‘Let’s all go for dinner.’ But the degree of dedication 
of the team in those days was always very important.
The second thing is about the laboratory: I went home to Ghana after getting 
the Membership of the Royal College of Physicians and they had heard that 
I had worked at the kidney unit at the Royal Free, so they gave me a kidney 
machine and asked me to get on with it. I said I wanted a week to decide about 
this. They said: ‘Why? You have got a kidney machine: get on with it’. I said: 
‘Look, give me a week, come back in a week and I will tell you.’ So as soon as 
they left I went into the ward and I took the blood of a patient called Attilo 
Ablo. I divided it into three. I put a third of the sample in a tube which had 
Attilo Ablo written on it. I put the second in a tube with another name on it, 
and the third sample in a tube with yet another name. And the laboratory came 
back with different values: the first had 80 mg of urea, the second 218 mg of 
urea and the third one was absolutely haywire. When those who wanted me to 
start dialysis came back, I said to them: ‘Look, where I was, at the Royal Free, 
they do not trust the hospital laboratory, they had their own lab at the side of 
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the dialysis room.’ I think that was extremely important for anybody to have in 
those days in order to make a success of dialysis. I must say I turned down their 
request and I went into haemoglobinopathy instead, which is now my specialty. 
Dialysis in Ghana had to wait until Dr Yaw Anim-Addo who had worked in 
Newcastle and Dr Dwomoa (Jo) Adu, who worked in the department of Dr Des 
Oliver in Oxford, arrived back in Ghana.102 They knew the value of a reliable 
laboratory and that was how we established kidney dialysis at the Korle Bu 
teaching hospital in Accra in 1972.103
The third point I want to make regards clinical acumen. In February 1965 I 
observed that my father-in-law had periods of somnolence, and he was having 
epistaxis. I told my wife that I thought he had kidney failure. He was English. 
I went to Stanley and I said to him, ‘I think my father-in-law has kidney failure 
and he is about 80 years old. I wonder if you could help’. Stanley saw him and 
found the urea content in his blood very high. Because of Stanley’s acumen he 
said to me: ‘Felix, he’s almost 80. We are going to put him on dialysis. If he has 
obstructive uropathy, he is likely to improve, but if he has glomerulonephritis 
producing a state of renal failure, I’m afraid we will have to dialyze him for 
another two weeks and stop’. And we agreed. He investigated him and found 
that it was a case of end-stage renal failure. I must say that during the two weeks 
that we had before he died, an extraordinary two weeks, he came round. He was 
clear in mind, singing hymns and rejoicing and it was amazing. So, these three 
things: dedication, a good laboratory and good clinical acumen.104
Cameron: A quick point, but I think an important one, and perhaps Robin 
Eady might like to comment, more from the inside, as it were. We have heard 
how nephrology was one of the earliest specialties, perhaps along with intensive 
care, which, of course, was growing during the 1960s in parallel with the 
introduction of technologies in medicine, which liberated nurses in to a huge 
variety of roles and gave them greater responsibilities than they had had before; 
and how important that was, as it turns out, in the shape of medicine as we 
know it today. 
102  Dr Felix Konotey-Ahulu wrote: ‘Dr Dwomua Adu FRCP is consultant physician, department of 
nephrology, Queen Elizabeth Hospital, Birmingham, UK, see Adu et al. (eds) (2001).’ Note on draft 
transcript, 1 August 2008. 
103  See Anon (1974).
104  Dr Felix Konotey-Ahulu wrote: ‘Some of the memorable publications on the unit (plus a recent 2008 
comment) include Konotey-Ahulu et al. (1965); Konotey-Ahulu and Anderson (1965); Baillod et al. 
(1965); Konotey-Ahulu (2008).’ Note on draft transcript, 1 August 2008. 
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I don’t think it’s too arrogant of nephrologists to claim that they helped to 
change the relationship between doctors and patients. I think nephrology, in 
many ways, was one of the first specialties that liberated patients. There had 
been areas that could have done this but in some ways didn’t: I am referring here 
to diabetes – from any time from the 1920s onwards, diabetics could have been 
given enormously more control over their own individual destinies and had 
their opinions and their views of the navigation of their disease path through 
life listened to. I think this first happened during the 1960s in nephrology. The 
idea that a doctor and a patient with a chronic condition take out a contract 
with each other, which is now standard in medicine and is quoted widely in all 
areas, was pioneered in the 1960s in nephrology, almost by default. I think there 
were leading speakers in favour of this attitude, including, of course, Stanley 
Shaldon, but I think it happened in numerous other units, almost by instinct.105 
We were going to ask patients to do so many things with their lives and in 
their lives, and we were going to invade their homes especially and so they 
would have to take more responsibility as well. I think that the role of increased 
nursing responsibility and the role of increased patient autonomy are two areas 
that nephrology significantly contributed to medicine in the past half-century. 
Pavitt: While we were talking about other disciplines, I felt that there were other 
people we ought to remember and recognize. First of all, the technical staff 
who actually ran the machines and played with the pumps and changed things. 
Many people will well remember Germaine, who built the Kiil dialyzers at the 
Royal Free, and her friend Agatha. When I first went to the Royal Free there 
were non-registered nursing staff who were very involved in managing dialysis, 
and I think a lot of what happened wouldn’t have gone on without them.
Professor robin eady: This will probably bring us in later to home dialysis 
where patients and their carers were so closely involved with day-to-day care. 
I think Stewart Cameron is absolutely right: dialysis did open up all sorts of 
avenues which hadn’t been looked at in this way before, in the relationship 
between the patients themselves, the medical staff, the technicians, the nurses 
and everybody else. I hesitate to use the term unique, but I think it probably was 
unique in its day. It didn’t only make for excellent management of the patients, 
but it illuminated how things could be done in other branches of medicine. I 
think it’s very sad to see – and this can come up later, perhaps – that this sense of 
empowering patients, giving them autonomy and making them responsible for 
their own treatment to a high degree seems to be diminishing in many ways. 
105  See, for example, Shaldon (1968). 
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Professor John Galloway: It seems to me that there is a bit missing from this 
very interesting discussion and I would like to ask a question. Nothing ever 
comes from nothing. What piece of kit immediately preceded these artificial 
kidneys? The way that the discussion has gone today gives the impression that 
suddenly they appeared. What was there before? Did they arise from some 
earlier piece of technology, whether it had anything to do with kidney dialysis 
or not? Does anyone know the answer to that question?
turney: Well, Stewart Cameron does, of course, in great detail, but essentially 
there was 100 years of science, going across membranes, osmosis, all these things.106 
There were attempts at clinical dialysis in Germany in the 1920s and 1930s, sort 
of one-offs, then heparin appeared.107 So there were lots of things going on in the 
scientific milieux that needed to come together. Whether they were deliberately 
put together by the three mentors is unclear, because the extraordinary thing 
about clinical dialysis was the simultaneous invention of artificial kidneys by 
Nils Alwall, Willem Kolff and Gordon Murray, and they were almost certainly 
isolated because they did it in 1943 or 1944, when they couldn’t talk to each 
other because they were in different continents and the Second World War was 
taking place. So, yes, it did appear apparently out of the blue and that’s the 
popular myth, but in practice there was a lot of science behind it.
Cameron: I think there were others, at least two other people who built artificial 
kidneys during the Second World War, one of whom actually used it as well, 
Jonathan Rhoads of Philadelphia in 1944, in addition to the big three, which is 
in my book, if you have a look.108 They all acknowledged that William Thalhimer 
was the person who gave them the idea of making practical dialysis and doing 
it. He was a laboratory haematologist in New York and was in contact with 
Charles Best’s laboratory, of Banting and Best and insulin fame. They were 
purifying heparin for Gordon Murray, who was one of the three who started 
dialysis, to use in cardiovascular and cardiothoracic surgery. So we had heparin 
and cellophane tubing simultaneously. Thalhimer somehow or other – we 
don’t know much about him and he certainly never said anything in his papers 
about how he got the idea – realized that the new sausage skin tubing made of 
106  See Cameron (2002): 8–31. See also the papers in Tosteson (ed.) (1989).
107  See Cameron (2002): 61–8 and page 22.
108  Jonathan Rhoads (1907–2002) was professor and head of the department of surgery at the University 
of Pennsylvania. See Rhoads in discussion after Fine et al. (1946); Barker (2005); Cameron (2002): 134–5 
and photograph on page 56. 
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cellophane, which itself had been around in sheets for 30 or 40 years, could be 
used together with heparin to make a practical dialyzer, because the older forms 
of dialysis that the science had led to, which John just mentioned, were highly 
impractical.109 If you read the accounts, it was obviously a nightmare dialyzing 
with hirudin extracted crudely from leeches, and collodion was a membrane 
that fractured easily and had to be prepared individually for each dialysis. If you 
can imagine using a hollow fibre kidney where you had to make each hollow 
fibre before the dialysis, you get some idea of what was involved. So I think 
the coincidence of three people popping up was inevitable, once Thalhimer 
had done his work. He was the guy I think we have to thank, even though 
he’s practically unknown today. Again, I have written about him in Nephrology 
Dialysis Transplantation in the past, but it is he whom all our dialysis patients 
have to thank, I believe.110 It was heparin and cellophane that made dialysis 
practical, although Thalhimer did not invent it either.
shaldon: I would like to come back to this problem of independence in dialysis. 
It was a dream and like many dreams it didn’t turn into reality. I think the tragic 
state today, as we will no doubt hear later, is the abysmal percentage of today’s 
patients who dialyze in the home worldwide; a problem perhaps not with 
technique but with the attitudes of people in welfare states who are perhaps 
more demanding than they used to be, or they are just older. For example, in 
Germany an organization I helped set up in the 1960s, the Kuratorium für 
Heimdialyse und Nierentransplantation, which was a specialized unit for home 
dialysis only, is today the largest provider of dialysis in the federal republic, with 
19 000 patients, and less than 1000 of these are now on home dialysis.111 I think 
109  Professor Stewart Cameron wrote: ‘From 1929 cellophane sausage tubing had been used for dialysis in 
the laboratory and Thalhimer transferred to this idea to continuous flow dialysis in vivo. See Andrus (1929); 
Drukker (1989).’ Note on draft transcript, 18 July 2008.
110  Cameron (2000b).
111  Professor Stanley Shaldon wrote: ‘In November 1966, I left the NHS and set up the privately funded 
National Kidney Centre in a house in Finchley, London, to demonstrate that dialysis could be done outside 
the hospital and that home training would be facilitated in a domestic setting. During the period 1966–68 
this resulted in installing more than 30 patients in their homes for dialysis throughout the UK. Following 
this preliminary period of activity the National Kidney Centre preoccupied itself with placing patients on 
haemodialysis in various places in the world as far afield as Colombo, Ceylon, Sri Lanka; Narvik, Norway 
and Lagos, Nigeria. In addition it established training centres for home treatment, particularly in Germany 
at University clinics of Frankfurt, Goettingen and Hannover, aided in the establishment of the Kuratorium 
für Heimdialyse and was responsible for placing the first 40 patients on the home haemodialysis in Germany 
between 1969 and 1972. See www.kfh-dialyse.de/kfh/kfh-historie.html (visited 19 May 2009). See also 
Shaldon (2004).’ E-mail to Ms Stefania Crowther, 21 July 2009.
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Chris Blagg wrote an editorial in the British Medical Journal recently lamenting 
the fact that this country’s attitude towards home dialysis seems to be following 
that of the rest of the world.112 I don’t believe that humans are not capable of 
doing this; I think the effort in achieving it seems to have switched now and it’s 
easier to put patients into service units and provide them with someone to do 
the work for them.
turney: There is also the issue of money that we haven’t really spoken about. 
I am hoping that Netar Mallick and others will talk to us about money and 
politics, because it’s quite interesting that the US figures show that home dialysis 
was decimated as soon as Medicare started to fund it and it became a very 
commercial thing.113 Also, although it’s not within the period of our meeting, 
and I am going to be very specific about this, CAPD appeared to be a viable and 
affordable alternative to home dialysis.
Baillod: Firstly, CAPD is extremely expensive, especially if it is done badly. 
The reason why they don’t do home haemodialysis is because the doctors and 
nurses are not prepared to spend the time teaching the patients. For someone 
to do home dialysis they need time and attention from staff who are short of 
time, because they have got to get on with the next job. It requires money 
too, as time to teach is expensive. Mind you, once you have taught the patient 
you get repayment for the time and effort, because, apart from the cost of the 
equipment, home haemodialysis is the cheapest form of dialysis treatment. It is 
a great shame that we rarely do home haemodialysis in the UK today.
Another comment about what dialysis did as regards the changing attitudes to 
patients: I remember clearly the business of sharing accommodation between 
males and females and we were having to defend ourselves to the matron. She 
was astonished that we had put a female patient with a male patient for dialysis. 
We said: ‘Do you want her to die or do you want her to live? It’s as simple as 
that.’ We should look at that.
Hamilton: A very brief answer to the very important question that was raised 
earlier – why was dialysis not considered earlier than the 1920s and 1930s and 
then suddenly came to the fore? A very interesting and profound question. We 
should try and get back into the mindset of physicians and medicine in general 
in the 1920s and 1930s, which had an holistic view of disease. I think one of the 
112  Blagg (2008). 
113  Nissenson and Rettig (1991). See also Blagg (2000).
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answers is that it was considered pointless to treat the kidney because the kidney 
was simply part of a diffuse disease in the body. We take a totally different view 
now: treat the kidney and the rest of the body is fine. I think you go back to the 
writings of physicians in that holistic period and they regarded it as a diffuse 
disease and thought it pointless to attack only one part of it. 
turney: Many people who lived through it thought that the pivotal event in 
British dialysis history was hepatitis and its consequences, and the events of the 
time. I think we will ask Netar to lead in with the Manchester experience.
Mallick: We were talking about how dialysing nephrologists were created; Geoffrey 
(Geoff ) Merton Berlyne, who really started dialysis in Manchester, was reader 
with Douglas Black.114 In 1965, when Douglas was on holiday, Berlyne opened 
up a couple of the side wards for regular dialysis as he called it. One couldn’t get 
into the ward without passing these side wards, but there wasn’t much space to 
clean everything up. Within a year there was a devasting outbreak of hepatitis 
that killed all six of the patients, a laboratory technician, one of the porters 
and one of the nurses, in rapid succession. Two distinguished physicians, Peter 
Ackrill and Jack Tinker, who are still alive, were also seriously ill at the time. 
The medical establishment in Manchester was not pleased by this, nor was 
the professor of medicine, Douglas Black. While that had a significant local 
effect, it also had a very significant national effect, because it occurred virtually 
simultaneously with the publication of the report of the working party which 
Hugh de Wardener chaired, which had agreed to set up a central initiative, 
20 dialysis units across the UK.115 The government was going to fund these 
and, as far as one could see, fund the consequences. Though that particular 
commitment was met, nothing else was met after that, in terms of government 
interest in dialysis provision, and this completely kyboshed its development. 
There was an editorial in the Lancet at virtually the same time which didn’t 
mention hepatitis, but pointed out that Hugh had worked out the cost, not 
significant in today’s terms, but it raised the point that in the end, it’s a matter of 
114  See Anon. (1993).
115  The working party on intermittent dialysis of the Ministry of Health (MoH) was established in May 
1965, following the recommendation of a MoH committee established in 1964 chaired by Lord Rosenheim. 
Records and papers of the working party are held at the National Archives, Kew, at MH150/7–20. See 
also Ministry of Health (1965); MoH (1966); Stanton (1999). An interview with Hugh de Wardener is 
freely available online at http://cybernephrology.ualberta.ca/ISN/VLP/Trans/deWardener.htm (visited 
1 April 2009). 
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economics.116 Did the country really wish to spend its money on dialysis or on 
something else? Of course, in the wake of the hepatitis outbreak, it was pretty 
clear what the answer was going to be for any government. So hepatitis had a 
huge impact on British medicine, because the devastating Manchester outbreak 
occurred at a time when critical central decisions were being made.
shaldon: Yes, we had yellow units at the Royal Free, if I remember correctly.117 
I think I can claim to be one of the first victims of that outbreak of hepatitis 
B and there was a segregation policy, which was never very well enforced in 
post-op yellow units. But then you got your vaccine and the problem sort of 
disappeared, didn’t it?
Mallick: Hepatitis C came along after that.
Goldsmith: We had 55 patients with hepatitis B altogether at the Sefton General 
Hospital, Liverpool, but were lucky, no deaths. When I say 55 patients, only a 
116  Five letters to the editor of the Lancet arising from the editorial, ‘Profit and loss in intermittent 
haemodialysis’ (20 November 1965), appeared on 11 December: Evans et al. (1965); Kerr et al. (1965); 
Blagg and Parsons (1965); Eady (1965); and Black (1965).
117  See Knight et al. (1970); Fox et al. (1971). 
figure 11: Professor Hugh de Wardener, (left) head of the renal unit at  
Charing Cross Hospital and Dr anthony Wing (right).
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few were dialysis patients.118 Most were relatives of patients on home dialysis, 
technicians, nurses and a doctor. We were threatened with closure, but, of 
course, they couldn’t do that. May I remind us that this was before we could tell 
which blood was infected, before the development of the Australia antigen test 
for infectivity and of a vaccine, and this led to obvious difficulties.
Baillod: We had most of our patients on home haemodialysis using leg shunts 
allowing them to be independent (Figure 13). It was expected that the nurses 
would put the needles into the hospital patients. We taught some of the home 
patients to insert the needles. Basically, each patient was independent. In late 
1967 an drug addict patient was sent to us. He was very uncooperative and 
peritoneal dialysis soon failed. During haemodialysis he would often pull out 
his needles and spray everyone in the room, including new sick patients. The 
patients did not become sick, but suddenly staff were going off sick with hepatitis 
B. At about the same time the academic liver unit at the Royal Free was able to 
test for hepatitis antigen, but they were selective in who they would test. It was 
not until we insisted that all staff and patients were tested that we discovered 
that there were patients who were Australia antigen-positive, but appeared 
healthy. Included in this group was our drug addict patient, who announced 
that all of his drug addict friends with whom he had shared needles went yellow, 
but he did not. At this point we realized that it was the silent carriers who spread 
the disease and he certainly was our source.119 The first hepatitis casualty, Lesley 
Pavitt, who is sitting behind me, was quite sick. We did not have any deaths 
and, because of the testing available, we were able to sort out the problem and 
deal with it. It all seems so simple now. 
ogg: I think the Guy’s epidemic (1969–71) was bigger than anybody else’s.120 
I counted 125 cases; there may well have been many more. I am not aware 
that anybody died. But a colleague, Stewart Cameron, had a serum bilirubin 
that reached 16mg per 100ml, was very sorry for himself and didn’t return to 
work for a long time.121 We didn’t have the Australia antigen test and we had 
no idea who was carrying the virus. Most of the patients who got it were fairly 
well. The staff were obviously ill. One thing that astonished me was that we 
118  See Hawe et al. (1971).
119  See Knight et al. (1970).
120  Ogg et al. (1972).
121  Professor Stewart Cameron wrote: ‘I was pretty convinced I was going to die.’ Note on draft transcript, 
11 July 2009. 
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continued to get staff coming to the unit. Doctors and nurses kept on coming in, 
which is greatly to their credit or lack of sense. I got very upset with the hospital 
administration because it failed to take responsibility for the health of agency 
nurses who got infected. Some poor girl would come in and do her bit, pick up 
our dreadful disease, then go away and be ill somewhere else. The hospital denied 
all responsibility for it. That upset me, but I couldn’t do anything about it.
turney: Just before we move on from you, what did Guy’s do with their unit?
ogg: We actually had an isolation unit built. By this stage testing for hepatitis 
was available and we could at least separate people who were Australia antigen-
positive and Australia antigen-negative. We implemented most, if not all, of the 
Rosenheim recommendations.122 We worked very hard to put people who were 
positive on home dialysis, providing a major impetus for expanding our home 
programme. John Goldsmith also gave us valuable advice. 
One of the factors that I think was responsible for maintaining our outbreak 
was the Kiil dialyzer. All of our patients were on Kiils and anybody who has 
used one knows that sometimes they leak. You do a lot of work to build a Kiil, 
sterilize it, connect the patient and then get a leak. You could either start again, 
rebuilding and sterilizing it in formalin before restarting dialysis, or you could 
use one of a pool of Kiils that were already assembled. I suspect that those 
were extraordinarily dangerous: it’s amazing that we actually had that policy 
in the late 1960s, but we did. That epidemic was my point of contact with 
Eric Collins, because we were well into flat-bed dialyzers for our chronics, and 
Rhône-Poulenc  and Gambro were the two firms who were producing disposable 
flat beds and it was for that reason that we switched to the Gambro flat beds.
turney: Netar Mallick said that there was political and economic effect and you 
are saying that there was a practice effect and you changed to disposables, which 
of course dominate now.
Pavitt: As Rosemarie Baillod said, I was ‘staff case one’ in the Royal Free paper.123 
I was taken into the Westminster Hospital as an unwell member of unknown 
origin and the consultant came round the next morning and said: ‘Oh, we have 
had your blood results back and you have got hepatitis.’ Well, I went ballistic 
and said to the consultant: ‘You have got to ring the Royal Free immediately.’ 
He said: ‘Now there, there dear, I don’t think we need to worry them about 
122  DHSS, England, Scotland and Wales (1972).
123  Knight et al. (1970).
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this.’ I had to get the trolley phone to ring the hospital to tell them, but by that 
time other cases had already come on. I thought that was very indicative of the 
attitudes of some paternalistic physicians in those days.
Professor neil turner: I am sorry that Ann Lambie can’t be here today, but she 
spoke at Robin Winney’s retirement in Edinburgh last year, at which time the 
story was told of the hepatitis B outbreak in Edinburgh in 1969/70, in which 
there were three staff deaths, including a transplant surgeon, a technician and 
a nurse, and eight patient deaths. Robin Winney told me later that no-one had 
ever dared to present that story in Edinburgh since the outbreak.124 Getting 
people to talk about it after that interval made clear what an enormous impact it 
had had on the practices of the unit, which had been unable to take on any new 
patients for a long period. Suffering the deaths of colleagues in a very small unit 
at that time had an impact both on the people in it and on the perceptions of 
nephrology from the other specialties in the hospital. Very difficult to measure, 
but, I am sure, extremely important. 
turney: I think that’s a very important point. Of course, Edinburgh had its own 
particular account, which was published by Colin Douglas.125 
Marsh: We opened our main regular dialysis unit at the London Hospital 
in 1968, having previously dialyzed a few patients between 1965 and 1968. 
We had virtually no problems with hepatitis at all. We were paranoid about 
hepatitis, having realized the problems in other units and so we were extremely 
careful in our dialysis techniques.126 When the Australia antigen testing came 
along we got Yvonne Cossart to test all transfused blood, our patients weekly, 
and the staff, I think monthly, and we were absolutely meticulous.127 We had 
one patient with hepatitis, and I think in the early days when we were testing 
for Australia antigen we had another two patients who became transiently 
positive, but it never spread. I don’t know why, except that we were paranoid, 
having heard about the other units’ problems. No staff were affected; perhaps 
we were lucky.
124  See Bone et al. (1971). See also http://renux.dmed.ed.ac.uk/edren/Unitbits/historyweb/Important%20
events.html #anchor11592281 (visited 3 April 2009). 
125  Douglas (1975).
126  Dr Frank Marsh wrote: ‘Before it was possible to test all transfused blood for hepatitis we used nitrogen-
frozen red cells.’ Note on draft transcript, 7 August 2009.
127  See Blumberg et al. (1968); Cossart (1971). 
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Hamilton: I have been through the Ministry of Health’s files covering this 
period and, as Sir Netar says, they were just at that point of priming the pump 
for funding the units when the news of the hepatitis outbreak came through. I 
am sorry to say there’s quite a cheeky note from Sir George Godber, the chief 
medical officer, saying, almost gleefully: ‘After this news we do not need to turn 
off the tap of money, it will turn itself off.’ It was a piece of cynical politics in 
the background of this.128 
There’s just one other point: of course, editorials were unsigned and anonymous 
and the Lancet contributed to the anti-renal unit mood in the country at that 
time and it might be nice for the proceedings if the author of those editorials 
could be identified for posterity.129 I think it is well known in the markets and 
in pubs who it was, but maybe it could be put in cold print.
Cattell: You talk about the economic consequences, but there were also serious 
social consequences. Stanley Shaldon has made the point that the nation was 
divided into units: those that had hepatitis and those that did not, and if you 
had a clean unit, you could not allow your patients to go on holiday. This was 
absolutely forbidden. Worse than that, we developed a mobile dialysis unit at 
one time, which some of you probably remember, and this was banned from the 
West Country, who didn’t want our nasty, dirty renal patients there. Finally, it 
also had quite an important point, that if you had a clean unit, when Australia 
antigen testing came along, what did you do when a patient presented with 
renal failure, who was positive? I have to say that we had enormous help at Bart’s 
from both Guy’s and, I think, King’s, both of whom would accept these patients 
so that we could stay clear of positive patients.130
Mallick: I understand that my previous boss, Douglas Black, wrote that 
editorial.131 He was by no means anti-therapy, he just took what he thought 
128  See Hamilton (1984). 
129  Anon. (1965).
130  Dr Chisholm Ogg wrote: ‘Mr Mick Bewick contracted hepatitis whilst working at Guy’s and was one 
of the few transplant/dialysis surgeons who was presumed immune to re-infection. He therefore offered 
invaluable help with surgical problems in infected patients from other units.’ Note on draft transcript, 22 
July 2008. 
131  Professor Stewart Cameron wrote: ‘I tried very hard to find out who authored the very influential Lancet 
editorials of 1965/6 on dialysis and hepatitis. My “suspect” was Douglas Black, but when I challenged him 
about this he said, “no”, but rather evasively, and I strongly suspect he had some role in them.’ Note on 
draft transcript, 18 July 2008.
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was a rational view of it. His secretary told me that he had a letter from 
Robin Fox, editor of the Lancet, saying: ‘Since your article appeared we have 
had to move to the basement, because there have been so many comments 
flying in through the front door.’ He took what in many ways was the 
rational view at that time. It’s all right with retrospect, but it wasn’t so easy 
to see at the time. 
By the early 1970s we had almost the same number of patients on renal 
replacement therapy as France and Italy, but 61 per cent of our patients were on 
home dialysis and in the Federal Republic of Germany and the rest of Europe 
it was about 20 per cent.132 We easily had the highest transplant rate, so this was 
the way that physicians tried to manage their patients in the face of government 
indifference and colleagues’ hostility. I have said this before, the fact that Stanley 
Shaldon had shown that home dialysis works saved the renal population on 
dialysis in the UK. It wasn’t what he intended to do, but that’s what he actually 
achieved in those years.
Baillod: I wonder if anybody has any comments about the hepatitis vaccine, 
because when the original vaccines came out they didn’t work for everybody.133 
For example, in our unit we were given the vaccine and when I suggested that 
we should test to see whether we had protection, I was told by the hospital that 
they did not do the test in their pathology department and they did not have 
the money to pay the academic liver unit to check whether I was protected or 
not. I made an enormous fuss to get the staff and patients checked and found 
that about 20 per cent of the people assumed to be protected did not have any 
protection. It wasn’t until better quality vaccines came out, up to five years later, 
that everyone got the protection they needed.
turney: While we are discussing complications, shall we talk a little bit about 
aluminium and water? Because we have David Kerr with us and we also have 
members of industry and there are lots of aspects to the changing practice from 
aluminium.
Baillod: I always thought we were getting messages from David Kerr that 
he had some peculiar bone disease in which some of his patients were 
wheelchair-bound, because they were developing spontaneous fractures. We 
had one patient transferred from David, Olga Heppell. She got spontaneous 
fractures of her ribs when she leaned over her tank to clean it. I would mutter 
132  See Parsons et al. (1974); Baillod and Moorhead (1974).
133  Maupas et al. (1976).
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under my breath: ‘It’s Newcastle water.’ In London we did not have this 
bone disease.
Kerr: We had this problem quite early, as soon as we started treating patients 
with chronic renal failure, and therefore they had a long exposure. Scribner 
kindly sent us two machines to let us do them and we only had enough places 
to treat two patients. They were doing very well after six months and Stanley 
Shaldon came to see us and he asked how the patients were doing. I said that 
they were getting on very well. There was one middle-aged lady, she was still fine, 
and there was a young lady who had been a nurse who grew up in Newcastle but 
had married an engineer in the south of England and then turned out to have 
chronic renal failure, and none of the hospitals around her would take her. She 
came back to Newcastle, thinking she was going to die, but her mother came 
to ask us if we would take her and so we took this lady in. Six months later, 
when Stanley came to see us, she was fine, except that when she got out to walk 
she got pain in the bottom of her feet. Stanley thought I was not treating her 
properly and that she had got neuritis. He was sure that he was right and I was 
sure that he was wrong. I said: ‘There’s something wrong with the bones’, and 
from then on we started seeing more patients with this. There was a young man 
who was going to university in Newcastle and he stepped out of his car one 
morning and fell on the ground. I happened to be standing there and I put him 
on a trolley and took him in to the hospital. We put him in an X-ray room and 
he had broken his femur, just getting out of the car. I thought: ‘We really have 
got a problem in Newcastle and it’s going badly.’ 
While we were trying to think what it could be, Mike Ward, who was in charge 
of home dialysis, came to me one day – by this time we were sending a lot of 
people out to be treated in their homes – and he said: ‘I have noticed that the 
people who have this bone disease are mostly from the north part of Newcastle 
and places beyond, while south of the Tyne very few of them seem to have 
this trouble.’ A very sensible observation and very important; it saved a lot of 
people. By this time we had been thinking it may be aluminium, but it might 
have been lots of other things. It wasn’t just in Newcastle; it was happening in 
Sheffield and in Plymouth and in many other places in the UK, as well as the 
US, Canada, Netherlands, and so forth. So there was something about it, but we 
never knew quite what it was. On that very same day I went to the waterworks 
on the north of the Tyne and saw them putting their aluminium sulphate into 
the water. Mike had made the statement, which I thought was very good, that 
to the south of the Tyne the hills were chalky and the water came from out of 
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them. In the north it is granite and what I was watching was removal of algae 
from that water by adding aluminium sulphate. 
As I walked back, I thought: ‘If it is aluminium, why are we having it? Because 
when water goes through water softeners, the aluminium would be removed as 
well as the calcium and magnesium.’ So, that evening I got out three major books 
about water treatment and each of them said that aluminium was taken away by 
water softeners. I noticed it was only said because they had tested it by putting 
aluminium chloride through a water softener. I knew that aluminium chloride 
was not used for removing algae, so I thought it still could be aluminium. And 
I was right. It took us about two years to get rid of the aluminium in our water 
and Mike did a great deal of the work on that.134 
When we realized what it was, we went to a meeting of the International Society 
of Nephrology in the US to talk about it, and we gave a talk entitled ‘the demise 
of Newcastle bone disease’. All my colleagues had their names on this statement, 
and at the end of it, it was accepted.135 However, not everybody believed that 
we were right, a lot of people still thought that aluminium was not the cause, 
although I thought we had proven that it was. Just after that, I went on a lecture 
tour across New Zealand and Australia, and when I got to Melbourne I gave 
a talk about aluminium poisoning and one of the audience was a professor of 
pathology who had been trained in the Hammersmith Hospital. After I had 
departed he went down to his room, picked up a book by his teacher at the 
Hammersmith Hospital and found there was a dye that shows aluminium. And 
so he took bits of bone that he had taken from people with bone disease and 
found the mauve line upon the ossification line which most of you know about 
now. Two weeks later I was back in England and opened the Lancet and there 
was his statement, and from then on everybody believed that it was aluminium 
and you could see it.
Dr Margaret Platts: In Sheffield, we were plagued with aluminium bone disease 
and encephalopathy, but our patients fell into two camps, those who had it 
and those who didn’t, and that depended on where they lived. Our region, as 
you probably know, goes right out to the east coast, and it was people near the 
134  Professor David Kerr wrote: ‘Michael Ward took on the job of setting up a new water purification 
machine for our dialysis unit with reverse osmosis, soft filter and a deionizer. He also persuaded the water unit 
to stop using aluminium for purification.’ Note on draft transcript, 6 August 2008. See Goodall (1974). 
135  See Kerr et al. (1986); Ward et al. (1978); Parkinson et al. (1981). 
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east coast who got this. They were all on exactly the same treatment, dialysis 
techniques and drugs and so on, and so it was naturally occurring aluminium 
in their diet or water that did it. This was before the time, of course, of the 
universal de-ionization of water.136
shaldon: I want to remark that the use of water softeners was a requirement 
if you were fortunate enough to have hard water and I think that aluminium 
bone disease and encephalopathy never developed in patients who were dialyzed 
with water softeners. Traditionally, Seattle had the gift of such pure water that 
they had no water treatment and those who ran into trouble with calcium in 
the early days quickly added water softeners and they never saw the aluminium 
disease. So, I think this shows the distribution of the kind of water before we 
ever understood what the causative agent was. 
Blagg: Stanley is quite right. The only thing in our Seattle water was debris 
that came down off the mountains in the spring when the snow melted. 
Consequently, for the first ten years or so, we just filtered our water to remove 
them. It wasn’t until Seattle city water was fluoridated in about 1970 that we 
began to use de-ionizers. David Kerr comes into our water story because in 
1967 we had trained a high government official from Khartoum in the Sudan 
to do home haemodialysis. A year or two later I got a call from David, who was 
an external examiner at the University of Khartoum Medical School, to tell me 
that every time the Nile flooded his patient became hypercalcaemic. 
turney: We have skirted around home haemodialysis. We keep mentioning it. 
Do the protagonists of home haemodialysis want to take this up?
Mrs ann eady: I think there are possibly people here who may have quite a large 
contribution to make to this and there’s one sitting behind me, Mary Selsby. 
While the doctors and nurses were training patients and their carers, there was 
an awful lot of work going on in the background with councils, new housing 
and plumbing. I am sure Mary Selsby, and also perhaps the patients themselves, 
will say how they felt because they were, after all, the reason for what we were 
doing.
Mrs Diana Garratt: I am a renal patient, started in 1969. This is quite an event 
for me, because normally when I am among clinicians, most of them were still 
136  Professor Stewart Cameron wrote: ‘Dr Margaret Platts was one of the first – if not the first – to provide 
clear evidence of the involvement of aluminium in dementia. Her contribution has been neglected as she is 
very modest. See Cameron (2002): 261.’ Note on draft transcript, 18 July 2008. See also Platts et al. (1973); 
Platts (1980); Platts and Anastassiades (1981).
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at school when I was starting dialysis. Not today, however. It was January 1970 
when Rosemarie Baillod came round to set me up at home on haemodialysis 
with my first shunt and I remember the room very well. We had a de-aerator, it 
looked like a toilet cistern, high on the wall above the bed (Figures 12 and 13). 
Actually, I think I was dialyzing on the table at that time, we hadn’t organized 
the bed. The rest of the family went on around us; we had a small TV, my 
younger brother and sister and the cat, who went very soon after because it 
was sitting there watching the pulsating blood lines and that was very nerve-
wracking, very, very nerve-wracking. We got through it, but it was an enormous 
effort. Every day you were either on the kidney machine, or you were hoping 
that the machine, which was not at all reliable compared with the modern 
machines, would work, that the kidney would not burst, that you wouldn’t have 
a blood leak. I had terrible vomiting as well in those early days. My mother, Dr 
Jean Northover, may touch on that, because she was the one clearing it up. I will 
hand over to her now, because she was the one who did all of the work.
figure 12: an example of home haemodialysis equipment, c. 1965: with Cambridge  
pressure and heat monitors, a tank system for dialysate, water softener and  
liquid concentrate, sterilized with formalin. 
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Dr Jean northover: It is very difficult to talk about home dialysis and to avoid 
all the clichés, because so much has been said about it. When I look back on the 
pioneer days, it would have been quite impossible if we hadn’t had the excellent 
backup that came from Lesley Pavitt and her nursing staff, and, of course, 
Rosemarie Baillod, who would come straight to the phone when required and 
thunder down the line what you should be doing, what you were doing wrong 
and then things would go right again. 
We staggered on for the first two years, assuming that dialysis reactions were 
really par for the course and that the first thing to do was to ring up the renal 
unit and see if Piriton® was needed.137 However, it got to the stage where the 
technicians were called in for sterilization of the water softener – this was used 
because we were in a hard water area in Hertfordshire – but that didn’t work. 
The reactions continued. Then all the other bits and pieces of the equipment 
were looked at and I realized that the more improvements we made to the water 
path, the worse the dialysis reactions became. So I went and had a good read 
up; as a retired scientist I knew how to set about things. The medical library 
at the Royal Society of Medicine became very useful and quite quickly I got 
into the work of Dr Hugh Lyle and Jeanette Blomfield out in Australia, who 
137  Dr Jean Northover wrote: ‘For sudden headache, chills, sweating, nausea, vomiting, and irregular fever.’ Note 
on draft transcript, 18 July 2008. Piriton® is an anti-histamine now manufactured by GlaxoSmithKline.
figure 13: Diana Garratt, née northover, 1969.
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were both looking at contamination of dialysis fluids.138 I found that three years 
previously here in England, Dr Lyle had said that he had analytical facilities 
in his laboratory at Dista Products, Speke, which he invited people to use if 
they would like to send in their dialysis fluids, because he felt that there was a 
risk of copper contamination of these fluids.139 So, of course, we took up the 
offer: dialysis fluids were sent off. By then, I have to say, that analysis was rather 
late in the day because Clifford Harvey, who is here today, and was formerly 
chief technician at the Royal Free Hospital renal unit, had already removed 
a 15-foot copper pipe from the water-path to the kidney machine. This had 
obviously been a good thing as reactions lessened. We had reduced the copper 
content, we imagined, of the incoming water. Nevertheless, the results from Dr 
Lyle’s laboratory were very useful as they indicated that there was metal pick-up 
occurring inside the kidney machine.140 Dylade were called in and replaced the 
copper-containing parts of the kidney machine with stainless steel parts and a 
installed cellulose Pall filter.141 We moved into an era when we were having no 
dialysis reactions. We had, in fact, rediscovered the wheel! We had done all the 
work checking the water and dialysate pathways and then made modifications, 
which we later found had been done by Manzler and Schreiner.142 There was 
nothing new in this.143 However, we were then into clearer waters. 
Next we had a charity chalet in Eastbourne with dialysis equipment and that was 
an area where a water softener was again required. Diana went down there. For 
the first days of the holiday she seemed to be alright. She had one small reaction 
but later she went back for another holiday and dialyzed, and had two massive 
dialysis reactions. I had taken polypropylene bottles with me for sampling the 
dialysis fluids. These were sent off to Dr Lyle at Speke and what he found was 
138  Lyle (1967); Blomfield et al. (1971).
139  Lyle (1969).
140  Lyle et al. (1976).
141  Pall Corporation was founded in Brooklyn, New York, in 1946 by Dr David Pall and began manufacturing 
blood filters for medical purposes in 1971. See www.pall.com/pdf/inv_pdf_Focus50Pt1.pdf (visited 
20 May 2009).
142  Manzler and Schreiner (1970); Ivanovich et al. (1969). 
143  Dr Jean Northover wrote: ‘In this connection Elga Group ((1969): 6–7) may be of interest. Professor 
George Schreiner, speaking about haemodialysis in the US said: “All copper parts have now been taken out 
of the commercially available dialyzers. I mention this because I have noticed here (in the UK) that some of 
the water lines have copper valves or copper-containing valves.”’ Note on draft transcript, 18 July 2008.
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that the levels of copper in those dialysis fluids were something of the order of 
500 micrograms per litre, which was comparable with those found in some of 
the Australian renal units.144 Again, the dialysis set-up – kidney machine and 
water softener – was cleaned up and reactions were then a thing of the past. Of 
course, copper in the dialysis fluid at these levels is probably not lethal in the 
short term, although extremely unpleasant. From our point of view, running 
home dialysis, we were jolly glad when we got rid of these reactions, because 
Diana had two siblings and really dialysis had to be a normal part of the family 
pattern; it couldn’t take priority. The other two children needed attention. 
The last thing I would like to say is that the funny thing about home dialysis is 
that when we had got past the ten-year mark – we went on for about 16 years 
before Diana got a transplant in 1985 – what we found was that you worked 
so hard and you had so little rest, that when finally you’d finished with the 
dialysis, the Kiil was put on the local dump and the transplant was working, 
you couldn’t really remember what you had been doing a lot of the time. So 
this was extreme, emotional, psychological and mental fatigue. I don’t know 
what the two sides of the brain were playing at! But I kept a friendship going 
with another dialysis mother, and she said, ‘I need you as my witness, because 
I have got to talk to somebody, I have got to know that we really went through 
it.’ She suffered from the same thing. So when people say, ‘Oh, go and learn 
French by total immersion’, I have to say that what we learnt on home dialysis 
was certainly ‘home dialysis by total immersion’.
turney: I think that’s very interesting. I wonder whether we can bring in Mary 
Selsby to talk about the wider aspects of home dialysis, because home dialysis 
was, as was pointed out by Netar Mallick, quite a transient British phenomenon 
and so it would be nice if we could dissect that a little.
Miss Mary selsby: I returned to the Royal Free Hospital in 1970 as the dialysis 
administrator, having left in the mid-1960s after completing my registered 
nurse training. Dr Rosemarie Baillod had instigated the post to facilitate the 
rapidly increasing home haemodialysis programme. Rosemarie’s reputation 
was garnered far and wide. At that point, we had patients all over the country, 
within a 250-mile radius, because we were looking after children.
Often the patient and their family were very grateful for the treatment and were 
delighted to be going home, but there were a number of aspects that I learnt 
144  Blomfield et al. (1969). 
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very quickly to come to terms with. Initial meetings with the patient and family 
were while the patient was hospitalized. I would briefly outline requirements for 
home haemodialysis and arrange a mutually convenient time to visit their home. 
I was frequently the last person any patient with renal failure wanted to meet, 
because when they met me it was confirmation that their renal function was not 
going to return, although they were always given this information by Dr Baillod 
prior to my first meeting with them. However good the doctors and nurses 
were at treating the patients, giving information and the best possible training, 
starting home haemodialysis was further confirmation that their kidneys weren’t 
going to work unless they had a successful transplant. 
In the early days, I had to liaise with the local authority. This was a nightmare 
because they weren’t always very happy about meeting the costs of the 
adaptations. The home dialysis treatment room requires a mains water supply 
and drainage to facilitate effluent from the water softener and dialysis machine, 
waterproof flooring and shelving, and a separate metered electricity supply.145 
There were many incidents with local authorities that told me what they were 
prepared to do, but couldn’t meet the cost, suggesting we treat the patient in 
the hospital: ‘It would be easier and a lot cheaper.’ Eventually, in the 1980s the 
change from local authorities undertaking the cost to the hospital meeting it 
was made, making life a lot easier.146
However independent we made the patients, what went on in their homes 
was a different issue. Frequently the spouse or partner provided considerable 
support. Few homes have spare space, and in the 1970s the dialysis equipment 
was considerably larger than that used today (Figure 12). Has anybody any idea 
what one month, two or three months’ supply of dialysis disposables is? Lack of 
adequate space to house the Dylade dialysis machine, water softener and Kiil 
board together with disposable dialysis supplies, salt and concentrate, might 
necessitate the building of an extension to the home or a cabin in the garden, 
145  See Grant and Whelpton (1974): 25. Miss Mary Selsby wrote: ‘Some authorities were very sympathetic 
and rapidly undertook the work. Others were obstructive, delaying the commencement of home treatment, 
inhibiting the patient's return to work, school or family commitments and blocking treatment facilities in 
the renal unit. In fairness, some authorities did find the costs difficult to meet.’ Note on draft transcript, 
22 August 2008.
146  Miss Mary Selsby wrote: ‘The renal unit budget met all the costs of home dialysis, the electricity used 
in the treatment room, the telephone installation and renal charges, plus the cost of the two-monthly 
replacement of dialysis disposables.’ Note on draft transcript, 22 August 2008.
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usually with covering from the house to the cabin. Only adults used the cabins.147 
No patient was ever allowed to dialyze at home without a functioning telephone 
in the treatment room. Many of them had never had a telephone in their house 
and as far as they were concerned, a phone in the house was the harbinger of bad 
news. I really had tremendous trouble with a lot of patients on this score. 
Patients were inordinately kind and very generous with their time and hospitality, 
but they were overwhelmed at having to cope; learning to dialyze independently 
at the same time as having adaptations done and equipment installed by renal 
technicians caused considerable strain. I liased with Rosemarie, the technicians, 
the nurses and, of course, the patient: at no time was the patient ever not told 
exactly what was going to go on. 
In the early days, the Kiil boards occasionally did not work, or very rare 
problems with blood access or equipment occurred and these could and did 
cause problems with employment for both patient and spouse. In the early days 
help with the extra costs for the renal diet has to be fought for. I won’t bore 
you with the ramifications of fights to get attendance allowances.148 The cost of 
home treatment to the hospital was certainly cheaper than hospital treatment 
and it was very successful for a majority of the patients, but the fights to get 
money for the patients were very difficult.
If anybody was likely to lose their job, I learnt to liaise very closely with unions 
and bosses, but never without the patient’s permission. I also liaised with schools 
so that the children got back to their studies as quickly as possible. We were very 
fortunate at the Royal Free to have a superb teacher in the paediatric department 
who also liaised with the schools. We did have trouble with school outings as 
teachers wouldn’t want to take a dialysis patient. I would ask: ‘Have you got any 
asthmatics?’ ‘Oh, well, yes, but they are different.’ ‘No. They are more difficult 
147  Miss Mary Selsby wrote: ‘The worst scenario would be having to re-house the patient and family. If this 
was necessary, the proximity of workplace, schools, public transport and extended family had to be taken 
into account. A major cause of anxiety to families was the possibility of having to change schools. In the 
majority of cases, space was somehow found.’ Note on draft transcript, 22 August 2008. 
148  Miss Mary Selsby wrote: ‘Little statutory help was available, the then renal diet was very expensive, help 
with travelling costs was meagre and social security benefits were not great. Fortunately help with costs of 
the diet and travel was finally instigated by the government. Applying for an attendance allowance was 
initially a minefield, frequently requiring at least three appeals. Unbelievably, re-applications were necessary 
even for children, fortunately legislation resolved the problems. Employing social workers specifically for 
renal patients has been of enormous benefit to patients and staff.’ Note on draft transcript, 22 August 2008. 
See Gordon (1974).
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to look after than a dialysis patient.’ We also had patients who would argue 
with teachers to be allowed to participate in sports and their teachers, being 
very protective, didn’t want them to do this.149 It was a very rewarding part 
of working in the renal field. I have tremendous admiration for patients who 
undertook home dialysis, and certainly for their spouses.150 
Pavitt: I want to add something much more technical. Looking back on it as I was 
coming here, thinking about it, I am amazed at the things that we managed to tell 
patients to do over the phone. Jean Northover said that they would ring up and 
you would think, ‘Oh, yes, you are going to have to change your bubble catcher. 
Now, get eight clamps and this is how you start clamping.’ I think now I would 
149  Miss Mary Selsby wrote: ‘In the early days, patients were dialysing ten hours a night, three nights a week, 
and haemoglobin levels were pretty low, thus patients often did not feel wonderful…frequently it had been 
years, if ever, since the child had had sufficient energy to play sports, persuasion resulted in a tired but happy 
child.’ Note on draft transcript, 22 August 2008. 
150  Miss Mary Selsby wrote: ‘Home dialysis was and is very successful for the majority of patients, but it will 
not work unless the hospital provides the best possible medical care, reliable vascular access and training, 
maintained equipment, nursing, technical and social support. This was unstintingly available from staff of 
the renal unit at the Royal Free Hospital.’ Note on draft transcript, 22 August 2008. 
figure 14: Pages from the diary of 11-year-old Diana Garratt,  
née northover, for 5–8 June 1972. 
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wake up in a cold sweat thinking that I was dreaming, but then it was absolutely 
normal. The nurse on the evening shift was one of them, she spent most of the 
evening on the phone, troubleshooting for patients on home dialysis.
Garratt: A quickie on school, following on from what Mary said about school 
trips. I was always very popular on school trips because I didn’t need to go to the 
loo. So, I would actually be the one looking after all the bags while others did. 
When it came to the academic work, because I did get round to some of that as 
well, I have in my diary for June 1972 – I was 11 years old at the time (Figure 14) 
– that on the Monday I had a really bad formalin reaction. The next day I went 
to school. There was an English grammar exam and I came second, and then in 
the afternoon there was a history exam and I came top with 88 per cent. 
Professor robin eady: I suppose it must be a sign of age, because I mainly 
remember the more amusing sides of dialysis, rather than the really bad times. 
But I should mention that after a few years on unit dialysis I had had the full 
works of acute complications: from formalin up the line, hard water syndrome, 
dialysis disequilibrium, bacteraemia, the full lot. The main problem I had on 
home dialysis, which became a major burden, was pyrogenic reactions. The way 
we solved this was, I suppose, through accident rather than design. I was also a 
home dialysis patient in the US when I had a fellowship in the university, ten 
years after starting dialysis. I managed to find that we got rid of these reactions 
by having a different sort of water treatment, organized by Christopher Blagg. 
I was probably the first home patient to have reverse osmosis, which Rosemarie 
and the technical team managed to install in my house after my return to 
London. We have heard something about the problems of water treatment, 
or lack of appropriate water treatment, but perhaps what didn’t come out 
was enough attention to what was happening in the water. We made a lot of 
assumptions, but I think that has already been discussed. That certainly was the 
major problem over the years for me, apart from those acute early problems. 
shaldon: I think this is an appropriate moment to pay some tribute to 
the dialysis nursing staff. As in my experience, many of them experienced 
nightmares on starting dialysis treatment of their patients exsanguinating 
from a disruption of the blood line. We have some people here who are well 
advanced in years, but I am sure not yet as old as some of the doctors, but 
would they like to confirm that?
Mrs ann eady: Yes, I am afraid so. One particular patient almost exsanguinated 
when I was on night duty and had left to check somebody else’s drip rate or god 
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knows what. When I returned the whole wall looked rather like a Jackson Pollock 
painting, worse than that, it was absolutely terrible. He had a double blood 
pump, so not only one line was spewing out, but two were. It was a complete 
nightmare, not only for me, but for him. He did survive, but it was terrible. 
Marsh: I am amazed that home dialysis was as successful as it was. The patients 
took an awfully long time to train; they were very highly selected in the early 
days of dialysis. In the early days we never took anybody over 50. We took one at 
55 who was a GP, but most of them were white, intelligent and relatively young 
and even then it was an enormous stress on them. The social consequences 
were enormous, the marital breakdowns were quite considerable. I used to show 
a slide of a ‘typical’ successful home dialysis couple. The wife was absolutely 
gorgeous, the husband was wonderful. She eventually died and he came up to 
me and said: ‘Frank, thank you for everything you have done, but home dialysis 
really is a nightmare.’ And for many patients it was. Not only were there worries 
about blood spills, but it also provided an opportunity for some patients to 
commit suicide. I remember being called by the police to one patient in the 
Southend area and they said that she had died, having disabled the alarms on 
her monitor. I went down post haste to her dialysis room and I literally waded 
through an inch of blood on the floor in galoshes. It was horrible. So we did 
put our patients through an awful lot. They were chronic dialysis patients and 
there was relatively little hope of transplantation in those days. Later on there 
was greater hope of transplantation and home dialysis fell out of favour for a 
number of reasons, including that. Now, of course, transplantation is a major 
problem because there aren’t enough transplants to go round. But I think that the 
nursing staff, the hospital administrative staff, the home dialysis administrators, 
the technicians and the patients really deserve a gold star.
Baillod: Soon after I’d said that we should select patients, I advocated not 
selecting but taking on everyone who presented to the unit; no one seemed to 
notice my change of opinion. The only people I would say I became selective 
with were children. I started looking after them from about the age of four and 
when they were at least ten kilos in weight. Weight was the more important 
factor for technical reasons. Age didn’t matter and anyway paediatricians did 
not have a real age limit: if you are nice you can be a paediatric patient until 
21, but if you are not nice you are transferred to adult units at 12. I was more 
careful in selecting children and families.
Obviously, there were patients who did not like or get on with dialysis. These 
patients had more accidents with their equipment, which always seemed to go 
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wrong. I was surprised by the number of patients who were illiterate. It was 
a learning curve to detect them as they were very good at covering up. They 
would not give you information if they had to write it down and if you pressed 
them they would get angry and make you back off. They were not stupid, but 
had just missed out on learning. They were quite able to dialyze themselves 
successfully. Also, I found the need to use different levels and types of speech 
within the English language in order to communicate and teach. The patients 
appreciate being able to talk to you on their level.
Quite a lot of patients who had been on home dialysis before having a transplant 
wanted to do home dialysis again after it failed, but it is not available for them 
today. I would not say that home dialysis was sweetness and light for everyone.
Booth: A general historical question: one cannot be anything but impressed 
by the sheer dedication and courage with which people have introduced this 
form of therapy. It must have been a dramatic, exciting period, but requiring 
immense dedication and commitment. The period you are discussing is a 
period during which medicine as a whole was dominated by numerical studies 
and epidemiology and that started, I suppose, with Bradford Hill and Richard 
Doll in 1950.151 It seems to me, listening to this story, that you are a group of 
people who have totally escaped the need to get your treatment approved by a 
Cochrane centre or a NICE committee. Is that in fact the case? Have you ever 
had to justify your activities to any of these protagonists of so-called evidence-
based medicine?
turney: Never, ever.
Mallick: Not so. NICE, in fact, did look at dialysis and came up quite positively 
about home dialysis, as it happens.152 But, I think Sir Christopher’s point is well 
made. In the days when this mattered, thank goodness, no. 
turney: And there was a Cochrane review on bicarbonate dialysate, which said 
it wasn’t very good; a bizarre conclusion.153 
Blagg: I agree with Rosemarie about much of what she’s said. As you may know, 
we have managed to have a home haemodialysis programme in Seattle for many 
years. We originally started in 1964 and you may have heard the story about 
151  See, for example, Doll and Hill (1954). See also Ness et al. (eds) (2002). 
152  See NICE (2002). 
153  Roderick et al. (2007).
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this. Les Babb was the professor of nuclear engineering at the University of 
Washington and in 1963 he began working with us to improve our dialysis 
technology. He took one look at the tanks we were using for dialysate and said 
we were stupid, and he and his engineering staff developed a proportioning 
system to make dialysate from concentrate and water for our four-station 
dialysis unit at the university hospital. When a 15-year-old daughter of one of 
his friends developed renal failure from systemic lupus erythematosus (SLE), 
she was turned down by the Seattle Artificial Kidney Center because she was 
under the age of 18 and had a systemic disease. Les and his staff started a 
crash programme to adapt the proportioning system for home use, and by the 
summer of 1964 Caroline was dialyzing successfully at home using a single-
patient monitored proportioning system that was the forerunner of most of the 
dialysis machines we have today in both centres and homes.154 Caroline lived for 
four years, finished high school and had two years at the university before dying 
of complications of her SLE.155 
Rosemarie talked about patient intelligence. We studied 100 consecutive 
patients whom we successfully trained for home dialysis and had a psychologist, 
Willard Snow, measure their IQs.156 The average was about 102 and the range 
was from 87 to 147. The psychologist said that’s just where it ought to be, as 
you don’t train people of really low-level intelligence to dialyze themselves. The 
IQ of 87 may have been an error because the patient was an 18-year-old black 
man and I suspect it was really educational deficiency, rather than anything 
else. He dialyzed at home successfully for four years until he got a transplant 
and it wasn’t until then that we discovered that for the last two years he had 
been dialyzing himself alone as the person who had been helping him quit after 
two years. 
We have also compared the demographics of our home haemodialysis population 
with those of all dialysis patients in Washington state and all US dialysis 
patients.157 The age distribution and other demographics are very similar, except 
that we have a much smaller black population in our state than nationally and 
so have fewer patients with hypertension as the cause of their renal failure. I 
154  See Babb (1995).
155  See Eschbach et al. (1966); Blagg (2007). 
156  Snow and Clark (1976). 
157  Professor Christopher Blagg wrote: ‘This is data I collected for a lecture and so it has not been published 
separately, but is included in Blagg (2005).’ Note on draft transcript, 8 July 2009. 
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think many more patients are capable of doing home haemodialysis than are 
doing so at present. I used to tell patients that if they can drive a car, they can 
drive a dialysis machine; in both cases you have to learn how to use it, how to 
handle problems and know where to get advice and support, but you need know 
nothing about what goes on inside the awe-inspiring machine. Obviously, there 
are many reasons why patients may not have access to home haemodialysis or 
may not wish to do so. I think that with modern equipment there is much less 
pressure on whoever helps the patient and more patients today are doing all or 
almost all of the dialysis themselves. To our mind, the patient should do just 
about everything that he or she can. 
Back to a comment Stewart Cameron made earlier about diabetes; Scribner 
always said that dialysis patients, in fact all patients with chronic disease, should 
learn as much as possible about their disease and take as much responsibility for 
their own treatment as they could. He said he learnt this from a diabetologist at 
the Mayo Clinic when he was a fellow there.
Pavitt: A quick comment: as somebody who spent nearly 18 years teaching 
patients how to manage their own dialysis at home, I would far rather have a 
patient who wasn’t very intelligent, because they did what they were told; the 
more intelligent ones would argue with you. 
Greenwood: A couple of questions, if I may: first, a comment for all the people 
who may be gloomy about what my generation has done to dialysis. I think 
there will be a resurgence of interest in home dialysis now, because of the need 
to do more frequent dialysis as a means of delivering more dialysis to improve 
survival. I saw my first kidney machine in 1978, so I am very much a latecomer. 
One of the complications that seemed to be apparent in patients then, which 
we used to send to the rheumatologists, was called ‘dialysis shoulders’. I use this 
term because this often used to come back as the diagnosis. Were the medical 
teams of the 1960s and 1970s aware that there was this long-term complication, 
later identified as dialysis-related amyloidosis?158 
The second question: did anybody have any concept in those days of the 
massively accelerated trajectory on to cardiovascular events suffered by most 
patients and even by young people on dialysis? As a senior house officer, I don’t 
recollect it entering my head how great the risk was. It is now a major concern, 
particularly in people who don’t get transplanted. I didn’t want to miss these 
two points in our history.
158  See Assenat et al. (1980); Bardin et al. (1986) and page 75.
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Blagg: A quick comment regarding Roger Greenwood’s question about 
cardiovascular complications. It wasn’t until the early 1970s in Seattle that we 
saw the connection, even though the very first Seattle patient died after 11 
years on dialysis with horrible coronary arteries and vascular disease. The first 
paper on the subject from Seattle was not published until 1974, so we were 
completely unaware of it early on.159
shaldon: Perhaps we were more aware of it in the UK. I grew up as a liver doctor, 
as I said, and one of the most important aspects of diet was to teach patients how 
to have a salt-restricted intake with their liver disease. So it came as no surprise 
when we started dialysis that when we wanted to treat these patients adequately, 
they were all put on a low salt diet and this has subsequently and remarkably come 
into disuse, particularly in this country and other Nordic countries, for various 
reasons. It’s incredible when you read in the British Medical Journal only last 
year an excellent article by Nancy Cook, with an enormous amount of publicity 
worldwide, on the benefits of a low salt diet in pre-hypertensive normals, with a 
highly significant reduction over a ten-year follow-up of cardiovascular disease, 
how the use of a low salt diet has virtually disappeared from the treatment of 
dialysis today.160 I think there is a large influence of ‘big pharma’ in this, in the 
belief that you can do it all with pills rather than via regimen. 
turney: We have skirted around selection. Clearly there was major selection 
or de-selection of patients in this period. Of course, the patients that were 
selected might be expected to have less cardiovascular disease than the 80-year-
olds nowadays and might be more amenable for home dialysis. Does anybody 
want to get into this murky water of how patients were chosen, referred or not 
taken on?
Baillod: The fact was that when we were referred patients, most had been pre-
selected by the hospitals and GPs who had decided others were not suitable. 
Even if you decided you would treat all patients, someone else had pre-selected 
them down into a narrow group. Even early on we treated diabetics and blind 
patients, but they had to fight their way through.161 What you have to remember 
is that all the patients had to fight very hard to get through to a dialysis unit.
159  Lindner et al. (1974); Lowrie et al. (1974).
160  Cook et al. (2007).
161  Professor Stewart Cameron wrote: ‘We did not really talk about diabetics, and how initially they were 
almost totally excluded. This story is told in Cameron (2002) but also in more detail in Cameron (2006): 
575–87.’ Note on draft transcript, 18 July 2008. See also page 73.
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Hoenich: Looking back, I think there is no doubt that the patients who actually 
appeared on dialysis were a totally different population from those we see today. 
If you go back and look at the figures – and I know that Rosemarie has just 
said that they were taking diabetics – around 5 per cent of the total population 
of patients on dialysis in the UK were diabetic, compared with around 35–40 
per cent today. I think Stewart Cameron will correct me, but there was also 
this implicit censoring, you know: ‘If you are over a certain age, well, perhaps 
this isn’t the best possible treatment.’ There was never any overt censoring in 
the same way as there was in the US where they had a committee to decide 
and Robin Eady spoke very eloquently about this at the Renal Association 
meeting the other year. I often sensed that we probably saw the best of the 
bunch progressing on to dialysis. 
Goldsmith: In the early days, the early 1960s, when we had to be highly selective, 
our only criterion for acceptance was: ‘Can we get this patient back to work?’ 
Blagg: I would say that the Seattle Artificial Kidney Center programme was 
responsible for the anonymous selection committee that everybody worries 
about, and still thinks about.162 It was probably the first time triage was overtly 
done in civilian practice, other than when disasters occurred, but according to 
Professor Al Jonsen in his book, The Birth of Bioethics, the publicity following 
an article in Life magazine in 1962 was the stimulus that led ultimately to the 
development of bioethics as a discipline.163
We didn’t use the committee after about 1969 as we had enough support from 
the state of Washington and private insurance companies, so that we were able 
to take everyone referred to us at that time – but we had almost no diabetics then 
and very few patients over the age of 65. In 1972 at the International Society of 
Nephrology meeting, I boasted that in Seattle we were treating 45 new patients 
per million of population, that 90 per cent of our 130 or so dialysis patients were 
on home haemodialysis and most were rehabilitated and we were not turning 
anyone down.164 Then, in 1973, the doors opened when the Medicare end-stage 
renal disease (ESRD) programme came in, providing universal entitlement to 
almost all patients with chronic renal failure, and diabetic and elderly patients 
flooded in.165
162  See Haviland (1965); Darrah (1987).
163  See Jonsen (1998): 211–14; Alexander (1962). See also National Kidney Disease Foundation (1963); 
Reynolds and Tansey (eds) (2007).
164  Blagg et al. (1972).
165  See Nissenson and Rettig (1999).
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turney: And it’s now, what, 200 per million?
Blagg: In the US it’s more than that. The incidence rate in 2005 was 347 per 
million population and the prevalence rate was 1569 per million population. 
We accept almost anybody and everybody now, whether they should be treated 
or not. 
Professor Monty losowsky: I wanted to make what is essentially the same 
point. I remember a time, quite a brief time, when I was a consultant in the 
1960s, when there was what we might describe now as the ‘Herceptin syndrome’ 
where we were forced to think about value for money, or cost effectiveness.166 
Medicine was less specialized in those days, so we used to look after a range of 
people. I am not a renal physician, but I remember having a young man with 
chronic renal disease and we were hoping to get him on to dialysis, but he had 
been ill ever since his schooldays. He had never had a career, he wasn’t married, 
he had no dependents and so we were told that it was unlikely that funds would 
be found for him. We were trying to work out a case, which is the sort of thing 
that we try to persuade NICE about now in other directions. 
Platts: We always had totally inadequate physical facilities for the number of 
patients who were referred to us and we had to have some form of selection. We 
tried to be totally unemotional about it. There were some people – not a good 
thing to say – who were obviously unsuitable. But we made it age-related, and 
anybody over 40 didn’t have a chance. That was in the early days.
Miss freda ellis: I had the privilege of working with Frank Parsons when I was 
a ward sister in Leeds in 1957. Chris Blagg might contradict me on this, but I 
think Dr Parsons’ feeling was that it should be ‘first come first served’. We had 
only one machine and I asked him how he decided which patient would be 
treated, and he said: ‘If the dustman comes before the duke, the dustman gets 
treated.’ I can’t remember there being any age discrimination. 
Blagg: In Seattle in 1962 the age limits for treatment were between the ages of 
18 and 45, eventually extended to 50. But remember, the committee also used 
‘social worth’ as one of the factors, and it has been said that if Henry David 
Thoreau had been referred for treatment, the committee would have turned 
him down.167 It’s also important to remember that in the early days there were 
very few opportunities for this expensive treatment and too many excellent 
166  See Blagg (2007). 
167  Sanders and Dukeminier (1968). 
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candidates, so the selection issue was very difficult. For example, Scribner 
estimated in 1964 that there were no more than 50–100 patients on transplants 
plus chronic dialysis in the US and the situation was unprecedented.168 Joe 
Eschbach and I ran a programme from 1965 to 1969 to train patients who 
could afford it to do home haemodialysis and then return home to other cities 
in the US and to other countries. The experience with the patients from abroad 
showed that home haemodialysis patients could be managed at distances of up 
to several thousand miles from the training programme.
ogg: One of our selection criteria was whether the patient could go on home 
dialysis. We had very tight hospital facilities and if there was no prospect 
of training a patient to go on home dialysis, this was a major factor against 
their selection.
I would like to make two very brief points about home dialysis. The first is that 
I have a sneaking feeling that it is the best way to get really good dialysis. The 
economic and space pressures on units is such that we have designed numerous 
formulae to calculate the minimum amount of dialysis a patient needs in order 
to survive. This never made much sense to me. But the days when you could 
dialyze somebody for ten hours, three times a week in hospital have gone and 
it is now only practicable at home. The hospital facilities simply aren’t there. 
I think it’s significant that we have two patients in the room who between 
them have got 40 years of dialysis experience, nearly all of it at home and not 
in hospital.169
The other point I wanted to make was about a device that I think has been 
underestimated in terms of its importance in dialysis and which I have always 
attributed to Stanley Shaldon, and that is the pressure monitor on the bubble 
catcher. It seems to me that relatively unattended dialysis, or home dialysis, 
would have been inconceivable without this simple device.170
shaldon: Historically, we had to teach the Americans how to do overnight dialysis 
with a simple monitor in the days when it all started in the home, I guess, or in 
the hospital in those days. I remember when Merrill’s group put their patient in 
the home, there was a famous meeting in Seattle in 1964; it’s actually written 
168  See Scribner (1964). 
169  Professor Robin Eady and Mrs Diana Garratt. 
170  Professor Stewart Cameron wrote: ‘I think Jo Joekes was the first to realize the importance of pressure in 
this part of the circuit, and modified the early Kolff drum dialyzer in 1947 or so to incorporate a pressure 
check.’ Note on draft transcript, 18 July 2008.
History of Dialysis in the UK: c. 1950–1980
73
down.171 I told them that when George VI had had a thoracotomy they had 
turned Buckingham Palace into an operating theatre and that’s what I thought 
Merrill’s group were doing with home dialysis at the time. They had a doctor 
and an acute dialysis system done in the home. I think that we – for simple 
reasons of no money, no staff and wanting to dialyze long hours – used the 
knife and just had a very simple device, originally a mercury U-loop manometer 
that could detect changes in pressure in the blood line system to pick up either 
a disruption or, when you had a pumpless blood flow system, a drop in the 
patient’s blood pressure. 
I would like to come back to one last remark, on which Netar Mallick probably 
has data. It’s my impression, and I have worked in three European countries, 
that there is no question that the rationing of dialysis mentality in the medical 
profession still exists in this country, compared with elsewhere in Europe, 
especially if one assumes that the incidence of end-stage renal disease is the same 
in the UK as it is in most western European countries. I still cannot understand 
how one can complacently sit back and, indeed, even publish today (as a certain 
group have published on geriatric ESRD) that it’s better to let them die than 
put them through the hell of dialysis. I think I am perhaps exaggerating the 
paper, but there is a plea not to dialyze old people. I am becoming old and 
I still want a few more years of life and this sort of stoical attitude, which is 
very characteristic, I think, of the Norwegians more than the British, to say: 
‘Stand over, old man, and let the young have the best’, is still prevalent in this 
population in the UK.
turney: Previous speakers did hint that a lot of the selection happened before 
they reached the nephrologists in this specific case. The diabetics just didn’t 
exist. Maybe this is something that we haven’t got time to explore very clearly.
Blagg: Our first diabetic patient was treated in 1969 and over the next two 
years or so, we treated a total of 12 diabetics and only four of them did well.172 
Of course, everything changed in the US in 1973 when virtually universal 
entitlement came along with the Medicare programme. I also want to make 
another comment: Stanley has made many great contributions to nephrology 
but, I think that telling us how to do home haemodialysis overnight, three times 
a week, was perhaps his greatest. Once we adopted this in Seattle in 1965, most 
of our patients were well rehabilitated, went to work or school or undertook 
171  Shaldon (1964).
172  See Blagg et al. (1971).
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other useful activities. Our state’s department of vocational rehabilitation 
was so impressed that they became our greatest financial supporters in about 
1967, paying for training, equipment and supplies for home haemodialysis 
patients. Of course, these were a selected group of patients. Also, one of the 
arguments we used with Congress to get them to legislate the Medicare ESRD 
programme was that most patients would be treated by home haemodialysis 
or a kidney transplant and would become taxpayers again. Little did we know 
what was to happen as a result of the entitlement and Congress completely 
underestimated what the costs would be. In fact, later that year, the New York 
Times ran an editorial about the unexpected costs of the programme and entitled 
it ‘Medicarelessness’.173 Also, people have forgotten that the use of nocturnal 
dialysis first came from Stanley, but over the years its use declined to very low 
levels. Now many nephrologists think it was invented in Toronto about 13 years 
ago – but what they developed there was more frequent nocturnal haemodialysis 
– often called nightly haemodialysis.174
Mallick: Stanley makes a point that I was thinking of making myself, that it is 
strange – and I am observing this without having to be intimately involved with 
it – that the number of patients taken on dialysis in the UK still remains low 
relative to population, and we have heard from people in this room who have 
used the methods of selection which are much more overt than how it is being 
done now. It is much more covert, but some sort of quizzical attitude to this, a 
questioning attitude, must still remain in the UK. How it is going to be teased 
out, I don’t know, but I would concur with Stanley’s basic point that there is a 
mismatch between what is taken on in the UK and what would seem to be the 
European norm for incidence, but interpretation is difficult.175
Baillod: I know about the U-tube with the mercury as Stanley had me go to 
Radio Spares to buy the little lights that flashed and a bell that would ring and 
I had to wire it up for him in 1964. We used it to measure negative pressure in 
the dialysate. 
173  Anon (1973).
174  See Uldall et al. (1996); Shaldon (2009).
175  See European Renal Association (2006): 22. Professor Stewart Cameron wrote: ‘I don’t agree. Some 
countries (e.g. Scandinavian countries, especially Denmark) have had completely free access to ESRD 
treatment for decades, but still find less than 100 per million population (ppm)/year with ESRD coming 
up. Others, such as Belgium, have three times this. Old UK post mortem data suggest 130 ppm/year for the 
UK in 1960, which, adjusted for diabetes and aging population, is just about what we are getting today.’ 
Note on draft transcript, 18 July 2008.
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I wanted to talk about two points that Roger Greenwood brought up when he 
was talking about the development of amyloid and bone disease. I used to do 
six-monthly X-rays on all the patients. I recently checked up on the papers we 
published. In one paper we had looked at the X-rays over a ten-year period and 
picked up on all the various points like atheroma, erosions and calcifications.176 
We referred to it as calcifications, rather than atheroma. We were making 
the observations. We knew vitamin D did not work and we were looking for 
other tests to measure what was happening with the bone disease. You see, one 
of the things we have not mentioned was that it was not routine to measure 
cholesterol and it was very difficult to measure parathyroid hormone in the 
1970s. Gradually we were able to make things fall in line. I gave a paper on the 
effects of dialysis in 1978.177 I had 71 patients who had been on dialysis for at 
least ten years. I described the pain they had in their shoulders, the stiffened 
hands and the knees being hot. This was amyloid developing over the ten years. 
We knew about the problems, but could not interpret them.
176  Tatler et al. (1973).
177  See Baillod et al. (1980).
figure 15: the hand of a patient on dialysis for more than ten years,  
who had pain, stiffness and age-related carpal tunnel syndrome, c. 1985. 
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Cattell: I would like to make a more general observation. I understand the 
object of this exercise is to record people’s experiences before we fall off the 
perch. One of our problems is that we all know how it was, but if you take the 
historian in 20 years’ time, he really wants to have an overview, and I would 
make the point, which I touched on earlier, that dialysis, especially home 
dialysis, changed the face of British medicine. It introduced the nurse specialist, 
teamwork, particularly in the home, as Mary Selsby has said. It introduced 
informality between staff, nurses and doctors, and it gave patients the chance to 
have their say. This really was a huge change in the manner in which health care 
was delivered in this country. 
turney: I think that’s a very important point. I remember the first time I was 
addressed by my first name by a patient, I nearly fainted. The temerity! But, of 
course, it’s now routine. Nobody has surnames or titles in hospitals now.
Greenwood: I don’t want to jump to the defence of my generation yet again 
about the attitude to dialysis, but I think there is a danger in measuring the 
success of renal services by the numbers of patients on haemodialysis, particularly 
in the renal centre. Many of us have realized now that the intense medicalization 
of the frail elderly and those carrying a heavy burden of disease is sometimes 
inappropriate. We are very blessed in this country to have an holistic attitude 
towards health and many of the units in the UK run very successful conservative 
management programmes in which patients are given the choice not to dialyze 
if the experience is likely to be too much. It has been shown that survival on 
dialysis in high-risk patient groups is no different from survival without it.178 So 
I think we have to be very careful and maybe a better measure of success is the 
number on self-care, by peritoneal dialysis or haemodialysis and the presence of 
a palliative care programme. We in the UK still have a chance not to allow the 
wholesale industrialization of haemodialysis by commercial companies, which is 
a very different role now adopted by industry from that of the gadget companies 
such as Gambro UK, which Eric Collins used to run. As we are approaching the 
era of reimbursement in this country, it is a serious possibility that we will end 
up like the US, where everybody tends to go on to haemodialysis ‘whether they 
should be treated or not’. That would be a tragedy. It’s been very interesting 
listening today. Everything we experienced in the 1960s and 1970s tells me that 
we cannot compare the dynamics of what is happening in health care now with 
what was happening then. 
178  Smith et al. (2003).
History of Dialysis in the UK: c. 1950–1980
77
Professor robin eady: A brief comment and then a question. Years ago Ann 
and I went, and we continue to go, to Sicily for holidays. I went for a conference 
there and had wonderful dialysis. They were starting a patient in her eighties 
on haemodialysis and they said: ‘Why not?’ In fact, they said: ‘She may not 
have many years to live, but we have many patients of this age, and they do 
reasonably well.’ I wouldn’t have been able to get dialysis in this country at the 
age I am now in those days. My question is really more philosophical, and I 
think we have to address this in this looking-back type of meeting: is dialysis 
today any better than it was at the time we are talking about, when we had 
home dialysis overnight three times a week for those lucky patients? Is it really 
any better today?
shaldon: I would like to object to Dr Greenwood’s comment. This is a type of 
attitude that one is seeing coming out of the UK more and more. As a Brit who 
has lived outside this country for the last 34 years, I find that this is a kind of an 
excuse-game that comes upon chaps when they are too old: ‘Let them die, they 
will be happier.’ I am not sure that this god-like decision-making of consultant 
medicine in this country should be tolerated. I think dialysis now should be a 
trial-and-error situation. But to say you are too old, because you are old – except 
if you happen to have your wits about you and be a member of the medical 
profession – is very selective and a little bit god-like. I totally disagree with your 
remarks about not treating old people.179
Cattell: May I make one amusing point? Diana Garratt made me think about 
it. Many years ago, in 1971, the European Dialysis and Transplant Association 
held a meeting in East Berlin, which many people here attended. In those days 
it was of interest to go to Checkpoint Charlie on the East German side. Now the 
only loo at Checkpoint Charlie was on the West German side, and one Robin 
Eady persuaded the East German guards to allow him to go to the Western side 
to empty his bladder, in which, of course, there was no urine.
179  Dr Roger Greenwood wrote: ‘It is worth noting that the acceptance of elderly and diabetic patients on 
to dialysis, which is much more liberal now than it was in the 1960s and 1970s, is no different in the UK 
from other European countries, evidenced by similar age and co-morbidity profiles of the renal replacement 
therapy programme. My previous comments were referring to the choice which is now given in many UK 
centres to the frail elderly, to patients approaching the end of life and to patients carrying a heavy burden 
of co-morbid disease not to dialyze if treatment is judged, by them, likely to be harrowing and futile. This 
is regarded by many as a positive achievement of multi-professional team working, which still survives in 
the NHS and which we can see from the proceedings, was probably originally introduced several decades 
ago by Stanley Shaldon and many of his colleagues present at this seminar.’ Letter to Mrs Lois Reynolds, 
2 August 2008.
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turney: I see dialysis patients have to be continuously inventive. I am going to 
draw the meeting to a close now and thank everybody for your contributions. I 
hope that you found it interesting and a chance to go down memory lane, but 
also to think about what times were like then and how those times have formed 
the way the specialty in dialysis is now. Thank you all for your contributions 
and, you never know, we may get a follow-up meeting.
tansey: May I reiterate the chairman’s thanks to you all for coming and 
contributing to this meeting. It’s been a fascinating afternoon. I have certainly 
learnt a lot. You are absolutely right in the comment that was made earlier, these 
are very valuable resources for future historians and so I do thank you all very 
much for coming and I thank our chairman for holding the meeting together 
so well. Thank you, John.
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Appendix 1
reminiscences of working with the Kolff rotating drum dialyzer  
at the Hammersmith Hospital, c.1947–1952
from Professor Kenneth lowe180
Lying in the desert (in Egypt on transit back from service in India) one day 
waiting for demob, I was reading the British Medical Journal and saw an advert 
for junior posts at the Hammersmith Hospital. I cabled my wife to apply on my 
behalf. Early in 1947 I arrived at the Hammersmith; in some ways a 30-year-
old veteran with an independent outlook, but I had to start at the beginning 
again. I attended Eric Bywaters’ rounds and I admired him. Graham Bull had 
arrived from Cape Town about the same time and I got to know him casually.…
When that six months as resident to Russell Fraser was up, I became one of the 
outpatient physicians and waited – but for what? Then chance. We juniors were 
all friendly and would meet in a club for a sandwich lunch and coffee. And so 
it happened that one day Jo Joekes asked me if I would be interested in joining 
him to work on the artificial kidney. Bywaters was leaving and Bull would be in 
charge. It meant three to four years of security of tenure if one showed research 
potential. Bull readily agreed. We became great friends. (24 December 2006)
It is amazing that the Hammersmith managed to do important research, 
especially on the heart, kidneys and liver, with modest resources. Britain was 
bankrupt after the war and still repaying Lend Lease. America was not a generous 
ally. The artificial kidney had to be improved where funding was available in 
rich countries. (3 November 2006)
Poor Britain had sold its foreign assets and was bankrupt halfway through the 
war and dependent on the US (Lend Lease) and then Marshall Aid postwar – at 
a cost. Rationing was at its worst postwar. We all had a very cold winter 1947/8 
(coal shortage). It was well into the 1950s before there was much improvement. 
(12 November 2006)
There was so much to be done in the postwar period that priorities had to be set 
and dialysis for some time had a relatively low priority. (20 February 2007)
180  Excerpts from a number of letters written in 2006/7 to Dr John Turney. The letters are wide-ranging, 
but these extracts are limited to Professor Lowe’s recollections of the use of the artificial kidney and the 
development of the conservative regimen for acute renal failure at the Hammersmith Hospital.
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A case could be made out for research funding to further develop the Kolff 
prototype in the UK wherever it would be of primary interest in a hospital 
that had technical help and possibly the prospect of commercial development. 
It was all a question of what priority should be given by funding policies. 
Perhaps too low a priority was accorded to dialysis in the UK in the early 1950s. 
(6 March 2007)
Very little clinical research was done in teaching hospitals. The Hammersmith 
was almost unique. It had staff members with brains and energy, but resources 
were meagre. We had a nurse/technician in the catheter lab and we got a BSc 
graduate, Barbara Evans, who learned to use the flame photometer. I wasn’t 
aware of any technical or light engineering available to improve the artificial 
kidney. (2 April 2007)
I suppose I was not impressed by the prototype artificial kidney. Improving 
the artificial kidney would need engineers, chemists and technicians of a high 
standard. Having travelled in the US, I no doubt expected the artificial kidney 
would be improved there. (24 December 2006) 
I never foresaw the development of chronic dialysis and I didn’t think much 
would be lost in waiting for the US to make efficient artificial kidneys. Acute 
tubular necrosis wasn’t all that common in peacetime. (2 April 2007)
It was the time when the prototype artificial kidney was beginning to show all 
its defects. But we were getting a lot of cases of anuria referred to us and I would 
spend the next three years doing renal clearances, studying the cases clinically 
and taking up Bull’s idea about tube feeding a synthetic diet and generally 
getting a better recovery rate in our patients. (24 December 2006)
The success of the Borst–Bull regimen in reducing the mortality from acute 
renal failure by careful medical and nursing care and especially by advising 
against mismanagements common at that time, was widely accepted. However, 
it was also agreed that improved artificial kidneys might/would further reduce 
the mortality. (6 March 2007)
The Borst–Bull regimen was saving lives and we wrote our Lancet paper in 1949 
almost as an emergency, so that other medical units could experiment with it 
and reduce their mortality rates, hitherto in the region of 90 per cent.181 More 
important was our paper in Clinical Science  in which we gave the first clear account 
of the pathophysiology of acute renal failure in the group of cases to which we 
181  Bull et al. (1949).
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applied the name ‘acute tubular necrosis’.182 We gave an account of our methods 
of assessing renal blood flow, glomerular filtration rates and tubular function. 
(19 February 2009)
I don’t think the Bull regimen was ever considered an alternative to dialysis. 
By ‘conservative management of anuric uraemia’, we proposed better clinical 
management as a holding operation. We were giving a clear account of the clinical 
picture of anuria or acute tubular necrosis, researching the pathophysiology 
and presenting a method of management that would reduce the mortality 
considerably. The implication was that the prototype Kolff kidney needed to be 
improved and problems of available antibiotics and heparinization overcome. 
That would be accomplished where facilities and funding could be provided. 
For that reason Kolff went to the US. Our two papers were well received and, 
I think, advanced the understanding and management of anuria. The Bull 
regimen, with or without modification, was widely used – by Kolff himself, 
Hans Brun and others. (12 November 2006)
The Kolff artificial kidney was a brilliant invention, but did it save lives, or save 
more lives than it endangered? Kolff ’s ‘success’ was a sulphonamide anuria and 
these cases usually recovered unless mismanaged. (3 November 2006)
In the medical corridor in the Hammersmith Hospital between 1947 and 1951, 
I recall that there were three labs on the left hand side and Sir John McMichael’s 
office was on the right hand side...we had the artificial kidney in the second lab. 
Eventually we got a building (shed) at the back of the Hammersmith for our 
kidney work. (12 November 2006)
Dialysis for acute renal failure was a long day’s procedure. The machine was 
set working using blood from the blood bank. It was important that the coils 
of cellophane tubing on the rotating cylinder did not leak into the fluid in the 
bath. Joekes was the expert on rotation couplings, which he sealed with what 
looked like sterilized Vaseline (I always watched with suspicion). Blood from 
the patient (a pint at a time) was fed by gravity from a stand, passed through 
the rotation coupling to the rotating drum, collected through the coupling at 
the other end and returned to the patient. I suppose we used both arms and 
cannulae in the veins. This was done for a good long time and seemed to involve 
a good many pints. Blood and bath fluid were monitored by the biochemistry 
182  Bull et al. (1950).
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lab. The patient had been heparinized and needed careful clinical watching. A 
patient with abdominal lesions might bleed (on occasion fatally). Infection was 
always a hazard. I can’t remember the temperature of the bath fluid. On one 
occasion the cellophane coil ruptured – the machine was switched off – the ends 
of the coil at the site of the rupture were clamped and an anastomosis made and 
we carried on. 
The three of us kept going with black coffee. It was a time of meat shortage 
and Bull got a regular supply of biltong, which he produced on these occasions. 
It was very salty. At the end of the day I might feel rather nauseated. Bull and 
Joekes came in early to start the procedure, I drove round the north circular road 
from Essex, arriving about 9 am. Bull and Joekes left in the early evening and I 
stayed overnight so that I could ‘clean up’, check that biochemical monitoring 
was complete and look after the patient. I could get a spare room and bed if 
need be. I remember one fatality at least (from fatal bleeding from an abdominal 
lesion). (12 November 2006)
Professor John McMichael (later Sir John) was pleased that the Kolff kidney 
was being used experimentally in the Hammersmith Hospital and gave a talk 
about it on BBC radio during the time I was there…The Kolff artificial kidney 
was still in use and I participated in its use in some desperately ill cases…It was 
about this time that Bull and Joekes were expressing doubts about the clinical 
usefulness of this prototype artificial kidney and considering the dangers of 
dialysis. The mystique and glamour of the artificial kidney and the fact that 
as distinguished a physician as Eric Bywaters had used it was the reason for 
cases of acute anuria to be referred to us from London undergraduate teaching 
hospitals and from regions outside of London. These peacetime cases were 
very different from wartime traumatic cases of anuria. The main groups that 
we identified were:
1. concealed accidental haemorrhage of pregnancy
2. criminal abortions
3. poisonings and sulphonamide anuria
4. mismatched blood transfusions and other ‘haemorrhagic nephroses’ 
(as they were called).
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We were able to identify common causes of mismanagement such as:
1. forced fluids and other causes of fluid and electrolyte imbalance
2. administration of potassium citrate
3. decapsulation of the kidney and other surgical procedures meant to 
initiate diuresis.
In those cases that came to us early, we described the period of anuria, the early 
diuretic phase and the late diuretic phase. They could merge into each other, 
but each had its dangers and different management.
This was a finite piece of research that kept us busy from 1948 to about 
1950. We then had to determine our future careers and research interests. 
We did not discredit the artificial kidney or even discard it. In the Lancet 
article we indicated conditions in which it might be used to supplement the 
Bull regime. The artificial kidney was left in the laboratory when we left.183 
(19 February 2007)
I had enjoyed my few years working on the kidney. I thought it important that 
we should document our early experience.184 I doubt if our conservative regimen 
delayed development of the artificial kidney: it reduced the mortality in the 
anurias from c. 90 per cent to less than 50 per cent meantime. Improvement of 
the Kolff artificial kidney and the development of other models was going on 
steadily abroad and such machines could be imported. (24 December 2006)
183  Dr John Turney wrote: ‘Lowe became a cardiologist and professor of medicine at Dundee. Bull and 
Milne were clinical physiologists and professors of medicine at Belfast and Westminster respectively; 
Bywaters became a rheumatologist; only Joekes remained within renal medicine.’ Note on draft transcript, 
26 February 2008. 
184  See, for example, Bull et al. (1957, 1958); Lowe (1952, 1953).
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Appendix 2
from sir Graham Bull (19 april 1979)185
At one time Kampen, in the Netherlands, rivalled Amsterdam in overseas trade 
but lost its importance as the river silted up. Before the war it became the 
administrative centre for the Noord Ost Polder, the area of reclaimed land in 
the north east of the Zuider Zee. A government laboratory for soil analysis was 
placed there and, during the war and the period when Kolff was developing the 
artificial kidney, was in charge of a man named W R (Rudd) Domingo, whom 
I believe was Javanese. It was, of course, important for the reclamation work 
to have regular determinations of electrolytes such as Na, K, Cl etc. and the 
laboratory used flame photometers for some of the determinations. It seems 
clear to me that Domingo must have played a very large part in making the 
artificial kidney a practical proposition by carrying out analyses for Kolff.186 
Very soon after the war, Kolff contacted Eric Bywaters who had defined the 
crush syndrome during the Blitz and offered him an artificial kidney. This 
reached the Hammersmith Hospital in the latter part of 1946, but, very soon 
afterwards, Bywaters was offered and accepted the post of director of the MRC 
rheumatology unit at Taplow. In February 1947 Bull came to the Hammersmith 
and joined the Bywaters team, which included A M Joekes and Kenneth Lowe. 
Bywaters left the Hammersmith soon afterwards and Bull was appointed lecturer 
with charge of the beds. Bull remained there until 1952 when he moved to the 
chair of medicine in Belfast.
During much of this period of about five years, the Hammersmith artificial 
kidney was the only one working in Britain and, as far as we knew, initially in 
the world. Kolff in America had the problem of setting up a new department 
and did not, as far as I know, treat patients for some year or three. The result 
was that Bull, Joekes and Lowe were asked to see many patients with acute 
renal failure and other forms of kidney disease. Most of these were in London 
and due to mismatched blood transfusions, abortions, concealed accidental 
haemorrhage and drug-induced causes.187 
185  Excerpt from a letter addressed to ‘David’, given by Sir Graham’s daughter to Professor Kenneth Lowe, 
original recipient unknown.
186  Dr John Turney wrote: ‘Cameron also emphasizes this opinion, see Cameron (2002): 116.’ Note on 
draft transcript, 13 July 2009. 
187  See Appendix 1, page 82.
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There was at the time very poor recognition of the importance of maintenance 
of water and electrolyte balance and many of the patients they were asked to 
see were in trouble on this account. Water and salt overload was very frequent 
indeed. We were feeling our way on the proper use of the artificial kidney – 
trying to define the most appropriate time to use it and simultaneously trying 
to determine the pathophysiology of the kidney failure and cause of death. 
Apart from salt and water overload, infection was important and contributed 
to causing death in quite a number of patients. We tried to keep the blood urea 
low, in the belief that end products of nitrogen metabolism were important, and 
used the artificial kidney sooner rather than later. However, as we appreciated 
the role of water and electrolyte disturbances and the possibilities of keeping 
the catabolic rate down by avoiding infection and the use of a protein free, 
‘protein sparing’ diet, as had been suggested by Borst, we delayed the use of the 
artificial kidney more and more. The first artificial kidney was not without its 
troubles. Every patient developed rigors about 20–30 minutes after starting and 
the open bath, which was kept at 37°C, was an ideal medium for the growth 
of organisms. Pinholes in the cellophane sausage casing used for dialysis also 
caused trouble.188
Another person who influenced the development of the conservative regimen 
was Francis Avery Jones who had realized early on the importance of fluid 
overload in causing death. Thus the conservative regimen was effectively a 
combination of Borst and Avery Jones.
It would not have been possible to use the artificial kidney or develop an effective 
conservative regimen without the free availability of electrolyte determinations 
at the Hammersmith and here Domingo comes into the picture again. Earl J 
King, the head of biochemistry and Klyne, senior lecturer, learnt of Domingo’s 
use of flame photometry on patients under Kolff and invited him to spend 
some time at the Hammersmith. Domingo and King then set up the flame 
photometer as a biochemical service instrument.
188  See page 22. 
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Dr rosemarie Baillod
LRCP MRCS (b. 1936) qualified 
at the Royal Free Medical School 
in 1961 and worked in the renal 
unit there (1964–98). Under the 
direction of Dr Stanley Shaldon 
in 1964, she taught the first home 
haemodialysis patient in the UK 
and Europe. She was involved 
in safety, design and efficiency 
of dialysis equipment and access 
surgery, oversaw the expansion of 
home haemodialysis and initiated 
a children’s home haemodialysis 
programme in 1969. She was 
also involved in the development 
of peritoneal dialysis in the 
home, setting up intermittent 
peritoneal dialysis in 1972 and later 
continuous ambulatory peritoneal 
dialysis in 1979. She has been 
emeritus consultant, Royal Free 
Hospital and emeritus honorary 
consultant, Great Ormond Street 
Hospital since 1998.
Professor Christopher Blagg
MD FRCP (b. 1931) qualified at 
the University of Leeds in 1954 
receiving his MD in 1964. He 
was lecturer and senior lecturer in 
the department of medicine at the 
University of Leeds (1958–66), 
working in the dialysis programme 
and received a US Public Health 
Service travelling fellowship to 
work with Dr Belding Scribner 
at the University of Washington, 
Seattle (1963/4). He moved to the 
University of Washington Medical 
School in 1966, and was professor 
of medicine there (1978–99), later 
emeritus. He was executive director 
of the Northwest Kidney Centers, 
Seattle (1971–98), president of 
the Renal Physicians Association 
(1975–77) and the Washington 
State Society of Internal Medicine 
(1981/2), chair of the scientific 
advisory committee of the US renal 
data system, National Institutes of 
Health (1988–93) and president of 
the American Society for Artificial 
Internal Organs (1997/8) and the 
Northwest Renal Society (2000–06).
Professor sir Christopher Booth
Kt FRCP (b. 1924) trained as a 
gastroenterologist, was professor of 
medicine at the Royal Postgraduate 
Medical School, Hammersmith 
Hospital, London (1966–77) and 
director of the MRC’s clinical 
research centre, Northwick Park 
Hospital, Harrow (1978–88). 
He was the first convenor of 
the Wellcome Trust’s History of 
Biographical notes*
* Contributors are asked to supply details; other entries are compiled from conventional 
biographical sources. 
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Twentieth Century Medicine 
Group (1990–96) and was 
Harveian Librarian at the Royal 
College of Physicians (1989–97). 
He is visiting fellow at the 
Wellcome Trust Centre for History 
of Medicine at UCL.
Professor John stewart Cameron
CBE FRCP (b. 1934) trained 
at Guy’s Hospital (now part of 
King’s College Medical School) 
where he spent most of his 
working career in research and 
care in renal diseases as professor 
of renal medicine. His work on 
dialysis began in 1962 at Cornell 
University, New York, and he has 
also been involved extensively in 
transplantation research as well as 
general nephrology. He is author of 
a number of articles on the history 
of nephrology. See, in particular, 
Cameron (2002).
Dr William r Cattell
MD FRCPE FRCP (b. 1928) 
qualified at Edinburgh University 
in 1951. After junior posts in 
Edinburgh, national service and 
posts at the Brompton Hospital, 
London and UCH, he was 
appointed medical lecturer at Bart’s 
in 1959 (senior lecturer, 1963); 
held a Rockefeller fellowship 
in Boston, MA (1963/4). He 
established NHS and academic 
departments of nephrology at Bart’s 
in 1969 and retired in 1991 as 
a senior consultant nephrologist 
and senior physician to St 
Bartholomew’s Hospital, London.
Mr eric Collins
FIOD (b. 1936) had a background 
in electronics in the Royal Air 
Force (RAF) (1953–57), where he 
was a radar specialist to the joint 
experimental helicopter unit, which 
took part in ill-fated action in 
Suez in 1956. On leaving the RAF 
he became a field engineer with 
Decca Navigator and was engaged 
in several of the H-bomb tests 
on Christmas Island (Kirikibati) 
(1957–59). He was pharmaceutical 
sales representative with Knoll 
and British Schering (1960–68) 
and specialist sales engineer with 
Rank Electronic Tubes (1968–70), 
leading to an offer from Gambro to 
establish their business in the UK 
in 1970, where he was managing 
director. 
Mrs ann eady
(b. 1944) qualified at the Royal 
Free Hospital (RFH) school of 
nursing, she worked as a student 
nurse, and later staff nurse in the 
dialysis unit, RFH Hampstead 
(1966–68), and then as a sister in 
the renal unit at Guy’s Hospital, 
London. She was a carer in home 
dialysis to her husband, Robin 
Eady (1968–87). She is currently a 
nurse specialist in contraception at 
the Margaret Pyke Centre, London.
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Professor robin eady
FRCP, FMedSci (b. 1940) 
graduated in medicine at Guy’s. As 
a Wellcome Trust training fellow, he 
worked in departments of medicine 
and biological structure at the 
University of Washington. He later 
became head of the department 
of cell and molecular pathology 
and dean at St John’s Institute 
of Dermatology, St Thomas’ 
Hospital, London. He is currently 
emeritus professor of experimental 
dermopathology, King’s College 
London, and honorary consultant 
dermatologist, Guy’s and St 
Thomas’ NHS Foundation Trust. 
His main research interest is in 
genetic skin disorders, and he 
founded the national epidermolysis 
bullosa diagnostic laboratory at St 
Thomas’. He began dialysis under 
Belding Scribner in February 
1963, later moving to Edmonton, 
Canada, and the Royal Free 
Hospital, London, under the care 
of Stanley Shaldon and Rosemarie 
Baillod. After almost two decades 
of home dialysis (1968–87) 
cared for by his wife, Ann Eady, 
including a period in Seattle 
(1972/3) he received a cadaveric 
renal transplant in Oxford. 
Miss freda ellis
(b. 1931) was a ward sister in the 
professorial medical unit at the 
Leeds General Infirmary (1957–86).
Professor John Galloway
LLM (b. 1942) was senior 
administrative officer at the MRC 
(1975–86); the Cancer Research 
campaign (1986–89); Nuffield 
Foundation (1989–93); Eastman 
Dental Institute (1993–96); and 
has been professor of biology at 
UCL, head of the dental team 
studies unit, Eastman Dental 
Hospital and expert adviser at the 
joint UCL/UCLH Biomedical 
Research Centre, UCL, since 1996.
Mrs Diana Garratt
(b. 1960, née Northover) started 
peritoneal dialysis at St Albans City 
Hospital in September 1969. She 
transferred to the Hammersmith 
Hospital and then Hampstead 
General Hospital, part of the Royal 
Free Hospital (RFH). In November 
1969 her haemodialysis began at 
the Royal Free Hospital renal unit, 
London, after Dr Rosemarie Baillod 
created an AV leg shunt. She started 
home haemodialysis, five days a 
week, in January 1970, cared for 
by her mother, Dr Jean Northover. 
She attended school full-time, and 
undertook voluntary work with 
occupational therapy, St Albans 
City Hospital. She was employed 
as a ward clerk (1979–81), and 
studied at the Chelsea School of 
Chiropody (1981–84), qualifying 
as a state registered chiropodist, and 
worked within the NHS and then 
in private practice. In February 
106
History of Dialysis in the UK: c. 1950–1980 – Biographical Notes 
1985 she received a cadaveric renal 
transplant at the RFH. She taught 
computing and Internet skills at 
various Hertfordshire colleges and 
continued with a small domiciliary 
chiropody practice. In 2008 her 
renal transplant began to fail and 
she returned to the transplant list. 
Mrs Diana Garratt wrote: ‘I am 
not a one-dimensional patient, 
“the renal failure in bed one”, but 
someone who has survived and 
continues to live with renal failure. 
Dialysis is a successful and proven 
treatment and even in the relatively 
primitive days of the 1960s and 
early 1970s when dialysis took 
many more hours per week than it 
does now, before erythropoietin, 
and the knowledge of vitamin 
D analogues and bone disease, 
patients did attend school and 
work.’ Note on draft transcript,  
18 July 2008.
Dr Henry John Goldsmith
MD FRCP (b. 1924) qualified 
at Guy’s Hospital in 1947 and 
held various junior posts in 
general medicine, neurology and 
paediatrics, served in the Royal 
Army Medical Corps in the Middle 
East (1948/9), worked with Willem 
Johan (Pim) Kolff at Cleveland 
Clinic, Ohio (1959) and Robert 
Kark in the University of Illinois, 
Chicago (1959–60). He became 
consultant to the artificial kidney 
unit and in general medicine, 
Sefton General Hospital, Liverpool 
Royal, in 1961 and founded the 
Merseyside regional association 
for kidney research (1964), the 
first of its kind in the UK, and 
the second UK unit to introduce 
home haemodialysis. He moved 
to the Royal Liverpool University 
Hospital in 1979, where he 
directed the Mersey regional renal 
unit and became manager of the 
hospital (1986–89).
Dr roger Greenwood
MD FRCP (b. 1947) qualified 
in medicine at the University of 
Bristol in 1976, following a first 
career in aeronautical engineering. 
After training in Manchester 
and Bart’s, London, he moved to 
Stevenage in 1988 to establish a 
new renal service for Hertfordshire 
and Bedfordshire, and has been 
clinical director of the Lister Renal 
Unit there since 1991. His research 
interests include haemodiafiltration, 
enhanced self-care dialysis and 
end-of-life issues. He was president 
of the British Renal Society 
(1997–2000) and chair of the 
Kidney Alliance (2003–07). He 
was lead author of the Kidney 
Alliance document Renal Failure: A 
framework for planning and service 
delivery (2001), which prompted 
government to produce the Renal 
National Service Framework (NSF) 
(2004/5). He subsequently became 
a member of the Renal NSF, an 
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external reference group, chairing 
the module addressing end-of-life 
and palliative care issues in kidney 
patients.
Mr David Hamilton
FRCPS (Gla), graduated from 
Glasgow in 1963, trained in organ 
transplantation with Sir Peter 
Medawar in London and later 
studied the history of medicine at 
the Univeristy of Oxford. He was 
a senior surgeon at the transplant 
unit of the Western Infirmary, 
Glasgow, Scotland and the first 
director of the Wellcome Unit for 
the History of Medicine at  
Glasgow University. 
Mrs olga Heppell 
was a nurse and renal patient 
who received the first home 
haemodialysis in Europe in 
November 1964, under the 
supervision of Dr Stanley Shaldon 
at the Royal Free Hospital, London. 
She used one of two modified 
two-layer Kiil artificial kidneys 
manufactured by her husband, 
Ron Heppell in Autumn 1964 at 
the Royal Free, the first of which 
was sold to Hugh de Wardener at 
Charing Cross Hospital, London. 
Ron Heppell went on to establish 
the company Heppell Engineering, 
Essex, UK, for the manufacture and 
distribution of dialysis machines in 
1965/6.
Dr nicholas Hoenich
PhD Csci Cphys MInstP (b. 
1946) graduated in physics from 
the University of London in 1965 
and subsequently obtained a PhD 
at Newcastle University in 1980. 
His interests are in the technology 
of dialysis and membranes. 
After a short period of working 
with Dr William Cattell at St 
Bartholomew’s Hospital, London, 
he worked as a scientific/senior 
scientific officer in the department 
of medicine, Newcastle University 
(1968–80) prior to being appointed 
to a lectureship in clinical science 
there. He was also president of the 
Association of Renal Technicians 
(1985–2007).
Mr John Hopewell
FRCS (b. 1920) qualified at 
King’s College Hospital, London, 
in 1943 and undertook surgical 
and urological training at King’s 
College Hospital, Royal Army 
Medical Corps (1945–48); Great 
Ormond Street Hospital (1950–
55); University of California, 
San Francisco (1955–67). He 
was appointed surgeon at the 
Royal Free Hospital, London, in 
1957 with a remit to establish 
a department of urology, and 
was founder and director of the 
renal unit there (1957–66); and 
a founder member of the British 
Transplantation Society (1971).
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Professor David Kerr
CBE FRCP FRCPE (b. 1927) 
was professor of renal medicine at 
Newcastle upon Tyne (1968–83), 
and professor of renal medicine 
and dean, Hammersmith Hospital, 
London (1984–92).
Dr felix iD Konotey-ahulu
MD FRCP DTMH (b. 1930), 
was born in Ghana, trained at 
Westminster Hospital School of 
Medicine, University of London, 
and did postgraduate work at 
Liverpool School of Tropical 
Medicine (1962) and Christ’s 
College, Cambridge (1970/1). 
He was research fellow in the 
department of medicine, Royal 
Free Hospital (1964/5); consultant 
physician at the Korle Bu Teaching 
Hospital, Accra, Ghana (1965–79); 
director, Ghana Institute of Clinical 
Genetics (1973–79); consultant 
physician and genetic counsellor 
in haemoglobinopathies in Harley 
Street, London (1979–2009), and 
the Cromwell Hospital, London 
(1983–2005); and Kewgyir Aggrey 
distinguished professor of human 
genetics, University of Cape Coast, 
Ghana (2000–09).
Professor Monty losowsky
FRCP (b. 1931) graduated from 
the University of Leeds in 1955, 
worked in Leeds, London, the 
University of Paris and Harvard 
University, Boston, Massachusetts, 
before being appointed professor 
of medicine in Leeds in 1969, 
dean of medicine and dentistry 
(1989–94), later emeritus. He has 
been visiting professor, University 
of Queensland, Australia (1996/7), 
and is at present executive chairman 
of the Thackray Museum, Leeds.
Professor Kenneth (Ken) lowe 
CVO MD DSc FRCPE FRCP (b. 
1917) was medical registrar and 
tutor at the Postgraduate Medical 
School, Hammersmith Hospital, 
London (1947–52) and emeritus 
professor of medicine, University  
of Dundee.
Professor sir netar Mallick 
DL FRCP FRCPI FRCSE qualified 
at Manchester University in 
1959. From 1965 he planned 
the renal unit in Cardiff, was a 
member of the Minister of Health’s 
working party on treatment for 
renal failure (1965–67), and 
became consultant physician and 
professor of renal medicine in 
Manchester (1967–2000), later 
emeritus. He was medical director 
of Central Manchester Trust 
(1997–2000), medical director of 
the national advisory committee 
on distinction awards (1999–2003) 
and on clinical excellence awards 
(2003–06). He was High Sheriff 
of Greater Manchester (2002/3), 
and was knighted in 1998. He 
has been president of the Renal 
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Association of Great Britain and 
Ireland, adviser to the government 
on renal disease, president of 
the nephrology board, Union 
European des Mèdicins Specialistes 
and chairman of the European 
Dialysis and Transplantation 
Association Registry. 
Dr francis (frank) Marsh
MA FRCP (b. 1936) graduated 
in natural sciences, at Gonville 
and Caius College, Cambridge, in 
1957 and qualified in medicine and 
surgery in 1960. Following junior 
medical and research posts at the 
London, Kent and Canterbury 
and Royal Free hospitals, he was 
appointed consultant physician, 
nephrologist and senior lecturer in 
medicine at the London Hospital 
Medical College in 1971. He 
became dean of medical studies and 
member of the council of governors, 
London Hospital Medical College 
(1990–95); chair of the North East 
Thames regional medical advisory 
committee (1986–90); member 
of the joint formulary committee 
of the British National Formulary 
(1986–2008); member of the 
executive committee of the Renal 
Association and of the specialist 
advisory committee on renal disease 
(joint committee on higher medical 
training). He is currently chair of the 
board of directors of the American 
University of the Caribbean. 
Professor Denis Melrose
MRCP FRCS (1921–2007) was 
professor of surgical science at 
the Postgraduate Medical School, 
London, and surgical registrar 
at the Hammersmith Hospital, 
London (1968–83), later emeritus.
Dr Jean northover 
PhD (b. 1928, née Payton) 
graduated in anatomy and 
physiology at the University of 
Birmingham; worked in industrial 
toxicology as physiologist 
technical officer at ICI, Welwyn, 
Hertfordshire, working mainly 
on organophosphates (1949–53); 
junior lecturer at the London 
Hospital Medical College in 1965 
and worked for her PhD (1958) on 
fortification of physiological saline 
for maintaining isolated organs; 
lecturer in the department of 
forensic medicine under Dr Francis 
Camps (1958–63), working on 
the estimation of barbiturates and 
other substances in post mortem 
specimens. In 1970, she became 
the first ‘home dialysis mother’ of a 
prepubertal child within the NHS 
when her eldest child, a patient of 
Dr Rosemarie Baillod at the Royal 
Free Hospital, was aged 9 and 
began haemodialysis at home.
Dr Chisholm ogg
MD FRCP (b. 1938) qualified at 
Guy’s Hospital Medical School 
in 1961, trained in nephrology in 
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1964 at the Institute of Urology 
with Dr A M Joekes and Dr A R 
Harrison and continued at Guy’s 
in 1969, where he remained as 
director of renal services until his 
retirement in 1998. During his 
career he published approximately 
150 papers, mainly on the clinical 
aspects of renal disease, including 
dialysis and transplantation.
Miss lesley Pavitt
(b. 1944) trained as a nurse at 
Guy’s Hospital (1963–66) and 
joined the renal unit at the Royal 
Free Hospital in 1967. She was 
promoted to sister in 1968 and 
clinical teacher in 1974. She 
was a founder member of the 
European Dialysis and Transplant 
Association and later a member 
of the committee (1979–93). 
She became a clinical teacher and 
nursing officer at St Bartholomew’s 
Hospital renal unit in 1977 and 
was deputy director of nursing,  
St Peter’s group (1987–95).
Professor John Pickstone
PhD (b. 1944) trained in biomedical 
sciences and in history and 
philosophy of science at UCL and 
Chelsea College, London (1973). 
Since 1974 he has worked at the 
University of Manchester Institute 
of Science and Technology and 
University of Manchester, where he 
founded the Wellcome Unit and the 
Centre for the History of Science, 
Technology and Medicine in 1986. 
Since 2002 he has been Wellcome 
research professor at the centre. His 
present projects include the recent 
histories of cancer, the artificial hip 
and the NHS in Manchester. 
Dr Margaret Platts
FRCP (b. 1924) trained and 
qualified in Sheffield in 1948  
and practised mainly in the 
department of medicine at 
Sheffield University, (1948–83) 
where, as consultant nephrologist, 
she inaugurated dialysis and the 
nephrology department in 1963. 
She spent a year in Baltimore, 
Maryland, in 1959, and for a short 
period, in Seattle, Washington, 
as a visiting fellow, working with 
Belding Scribner.
Professor leslie Pyrah 
CBE (1899–1995) was honorary 
assistant surgeon, Leeds General 
Infirmary (1934–44); surgeon  
with charge of out-patients  
(1944–50); senior consultant 
surgeon, department of urology, 
Leeds General Infirmary (1950–
64), honorary director, MRC unit 
(1956–64); lecturer in surgery, 
Leeds University (1934–56); 
professor of urological surgery 
(1956–64), later emeritus.
Professor Belding scribner
MD (1921–2003) qualified 
at Stanford University School 
of Medicine in 1948, and was 
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professor of medicine at the 
University of Washington School of 
Medicine (1951–90). He designed, 
with Wayne Quinton, a U-shaped 
device made of Teflon, later called 
the Scribner shunt, in 1960. See 
Lenzer (2003); Blagg (2006). 
Miss Mary selsby
(b. 1934) trained and nursed at 
the Eastman Dental Hospital, 
London (1953–59), and trained as 
a nurse at the Royal Free Hospital 
(1962–5) and as a midwife at 
the Royal London and St Mary’s 
Hospital (1966/7). She was a health 
visitor in the London Borough 
of Camden (1968–70), a home 
dialysis administrator and later 
renal services manager at the Royal 
Free Hospital (1970–96). She was 
a founder member, committee 
member, newsletter editor and 
journal editor of the European 
Dialysis and Transplant Nurses 
Association (1974–86).
Professor stanley shaldon
MD FRCP (b. 1931) qualified 
at Queen’s College, Cambridge 
and trained at the Middlesex 
Hospital, London, and later as 
houseman and registrar at the 
Postgraduate Medical School, 
Hammersmith Hospital, London, 
in the department of medicine 
with Professor John McMichael. 
He was lecturer in medicine 
(nephrology) at the Royal Free 
Hospital Medical School (1960–
65); consultant physician at the 
Royal Free Hospital (1965–66); 
medical director, National Kidney 
Centre, London (1966–74); and 
professor of nephrology, University 
of Montpellier, France (1974–96).
Professor e M (tilli) tansey
PhD PhD FMedSci HonFRCP  
(b. 1953) is convenor of the 
History of Twentieth Century 
Medicine Group and professor 
of the history of modern medical 
sciences at the Wellcome Trust 
Centre for the History of Medicine 
at UCL.
Professor neil turner
FRCP (b. 1956) qualified at the 
University of Oxford in 1980 and 
has been professor of nephrology 
and consultant in renal medicine 
at Edinburgh University and Royal 
Infirmary since 1998. He has a 
scientific research group working 
on autoimmunity in the MRC 
centre for inflammation, Queen’s 
Institute for Medical Research, 
Edinburgh. He established EdRen, 
the website of the Edinburgh renal 
unit, (www.edren.org) in 2000 and 
has steered the renal patient view 
project, in which patients access 
their own results on the web, since 
its initiation in 2004. He has been 
chairman of Kidney Research UK 
since 2007.
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Dr John turney
MD FRCP (b. 1948) qualified 
at Cambridge and King’s College 
London, held posts in London 
and Birmingham, including 
Wellcome research fellow at King’s 
College London, where he worked 
on prostacyclin, coagulation 
and dialysis (1978–84). He was 
consultant renal physician, Leeds 
General Infirmary (1983–2005). 
Since 2006, he has been pursuing 
postgraduate studies at the 
Centre for the History of Science, 
Technology and Medicine, 
University of Manchester.
Professor Hugh de Wardener 
CBE FRCP (b. 1915) qualified at 
St Thomas’ Hospital in 1939 and 
joined the Royal Army Medical 
Corps. After the war, he returned to 
St Thomas’ as a lecturer and started 
work on renal physiology, salt and 
water balance, and acute renal 
failure. He was chair of medicine at 
Charing Cross Hospital, London 
(1960–81), later emeritus.
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